Zusammenfassung
Seit der Veröffentlichung des Handbuchbeitrages von Königstein Über die Amyloidose der Haut im Jahre 1932 sind keine grundlegenden neuen Tatsachen hinzugekommen; wohl aber ist das Krankheitsbild der primären Amyloidose oder Paramyloidose dadurch, daß viele neue Fälle gründlich bearbeitet worden sind, besser in seinen Einzelheiten bekannt geworden. Auch sind die Beziehungen zwischen Paramyloidose und Plasmocytom, die schon Königstein kurz erwähnt, eingehend diskutiert worden. Ferner hat sich ergeben, daß die sekundäre oder „echte“ Amyloidose die Haut nicht befällt. Diesbezügliche Fälle, wie sie von Schilder und von Michelson und Lynch (1934) beschrieben wurden, gehören wohl der Paramyloidose an (Gottron 1950). Daher wird hier nur die Paramyloidose besprochen werden.
Chapter PDF
Similar content being viewed by others
Literatur
A, I. Ablagerung von Amyloid (S. 43)
Apitz, K.: Die Paraproteinosen. (Über die Störung des Eiweißstoffwechsels bei Plasmocytom.) Virchows Arch. path. Anat. 306, 631 (1940).
Atkinson, F. R. B.: Multiple Myeloma. Med. Press 195, 312, 332 (1937).
Bannick, E. J., J. M. Berkman and D. C. Beaver: Diffuse amyloidosis; three unusual cases. Arch. intern. Med. 51, 978 (1933).
Bayrd, E. D., and W. A. Bennett: Amyloidosis complicating myeloma. Med. Clin. N. Amer. 34, 1151 (1950).
Becker, W.: Paramyloidose im Gesichts- und Kehlkopfbereich. Z. Laryng. Rhinol. 33, 71 (1954).
Binkley, G. W.: Primary systemic amyloidosis. Arch. Derm. Syph. (Chicago) 37, 330 (1938).
Bizzozero, E., et A. Midana: Sur l’amyloidose cutanée. Ann. Derm. Syph. (Paris) 10, 18 (1950).
Bloom, D.: Amyloidosis cutis, extensive. Arch. Derm. Syph. (Chicago) 66, 130 (1952).
Bluefarb, S.,A. Wallk and M. L. Gecht: Primary systematized amyloidosis associated with multiple myeloma. A.M.A. Arch. Derm. 75, 889 (1957).
Brunsting, L. A., and I. D. Macdonald: Primary systematized amyloidosis with macroglossia: a syndrome related to Bence-Jones proteinuria and myeloma. J. invest. Derm. 8, 145 (1947).
Bürümcekci, K.: Mitteilung eines Falles von atypischer Amyloidose (Paramyloidose). Virchows Arch. path. Anat. 302, 607 (1938).
Chester, W.: Multiples Myelom und Hypoproteinämie. Z. klin. Med. 124, 466 (1933).
Dahlin, D. C.: Primary amyloidosis, with report of six cases. Amer. J. Path. 25, 105 (1949).
Dahlin, D. C., and M. B. Dockerty: Amyloid and myeloma. Amer. J. Path. 26, 581 (1950).
Degos, R.: Amyloidose systématisée (Association à un myelome multiple des os). Ann. Derm. Syph. (Paris) 83, 361 (1956).
Dick, G. F., and L. Leiter: Experimental amyloidosis and hyperglobulinemia. Trans. Ass. Amer. Physicians 52, 246 (1937).
Dillon, J. A., and L. R. Evans: Primary amyloidosis. Report of three cases. Ann. intern. Med. 17, 722 (1942).
Ehrström, M. D.: Chondroitinschwefelsäuren, Heparin, Albuminurie, Amyloid und Serumproteine. Acta med. scand. 101, 551 (1939).
Eisen, H. N.: Primary systemic amyloidosis. Amer. J. Med. 1, 144 (1946).
Elles, N. B.: Amyloid disease of the conjunctiva. Amer. J. Ophthal. 28, 486 (1945).
Engel, R.: Purpura bei Paramyloidose. Klin. Wschr. 24/25, 368 (1947).
Eppinger, H.: Zur Chemie der amyloiden Entartung. Biochem. Z. 127, 107 (1922).
Faber, M.: The serum glucosamine with particular regard to its significance in connection with the origin of amyloid deposits. Acta med. scand. Suppl. 206,351 (1948).
Fagraeus, A.: Antibody production in relation to the development of plasma cells. Acta med. scand. Suppl. 204 (1948).
Ferris, H. H.: Amyloidosis of lungs and heart. Amer. J. Path. 12, 701 (1936).
Findley Jr., J. W., and A. Adams: Primary systemic amyloidosis simulating constrictive pericarditis with steatorrhea and hyperesthesias. Arch. intern. Med. 81, 342 (1948).
Fisher, H., and F. S. Preuss: Primary systemic amyloidosis with involvement of the nervous system. Amer. J. clin. Path. 21, 758 (1951).
Freeman, I., and L. A. M. Krause: Multiple myeloma with localized amyloid deposits. Bull. School Med. Univ. Maryland 26, 17 (1941).
Gabriel, H., u. W. Lindemayr: Amyloidosis cutis nodularis atrophicans. Dermato-logica (Basel) 115, 508 (1957).
Gerber, J. E.: Amyloidosis of the bone marrow. Arch. Path. (Chicago) 17, 620 (1934).
Gerstel, G.: Über atypische Lokalisation des Amyloids, insbesondere Über die Makroglossia amyloides diffusa. Virchows Arch. path. Anat. 283, 466 (1932).
Giles, R. B., and E. Calkins: Studies of the composition of secondary amyloid. J. clin. Invest. 34, 1476 (1955).
Götze, W., u. W. Krücke: Über Paramyloidose mit besonderer Beteiligung der peripheren Nerven und granulärer Atrophie des Gehirns. Arch. Psychiat. Nervenkr. 114, 183 (1941/42).
Golden, A.: Primary systemic amyloidosis of the gastrointestinal tract. Arch. intern. Med. 75, 423 (1945).
Goldman, M. J., and G. Gerstel: Primary systemic amyloidosis. Calif. Med. 71, 36 (1949).
Goltz, R. W.: Systematized amyloidosis. A review of the skin and mucous membrane lesions and a report of two cases. Medicine (Baltimore) 31, 381 (1952).
Gottron, H. A.: Systematisierte Haut-Muskel-Amyloidose unter dem Bilde eines Skleroderma amyloidosum. Arch. Derm. Syph. (Berl.) 166, 584 (1932).
Gottron, H. A.: Amyloidosis cutis nodularis atrophicans diabetica. Dtsch. med. Wschr. 75, 19 (1950).
Gottron, H. A., u. G. W. Körting: Über Ablagerung körpereigener Stoffe (Amyloidosis, Calcinosis) bei Morbus Osler. Arch. klin. exp. Derm. 207, 177 (1958).
Grayzel, H. G., M. Jacobi, H. B. Warshall, M. Bogin and H. Bolker: Amyloidosis: experimental studies. Arch. Path. (Chicago) 17, 50 (1934).
Greenbaum, S. S., and J. T. Bauer: Primary lichen amyloidosis. Report of necropsy. Arch. Derm. Syph. (Chicago) 55, 251 (1947).
Groenewegen, J. Th.: Amyloidosis cutis papulosa und multiple Myelome. Der-matologica (Basel) 109, 228 (1954).
Hass, G.: Studies of amyloid. II. The isolation of a polysaccharide from amyloid-bearing tissue. Arch. Path. (Chicago) 34, 92 (1942).
Hayman Jr., J. M., H. E. MacMahon and J.F. Patterson: Primary amyloidosis. Bull. New Engl. med. Cent. 15, 115 (1953).
Heilmeyer, L., u. H. Begemann: Hautkrankheiten bei Dysproteinämien. Hautarzt 1, 59 (1950).
Higgins, W. H., and W. H. Higgins Jr.: Primary amyloidosis. Clinical and pathological study. Amer. J. med. Sci. 220, 610 (1950).
Holtzman, I. N., and J. Skeer: Amyloid ”tumor formation” of skin. Arch. Derm. Syph. (Chicago) 67, 187 (1953).
Iverson, L., and A. B. Morrison: Primary systemic amyloidosis. Arch. Path. (Chicago) 45, 1 (1948).
Jones, S. R., and D. B. Frazier: Primary cardiovascular amyloidosis. Clinical manifestations, pathology and histogenesis. Arch. Path. (Chicago) 50, 366 (1950).
Josselson,A. J., R. D. Pruitt and J.E. Edwards: Amyloid localized to the heart. A.M.A. Arch. Path. 54, 359 (1952).
Joulia, P., P. LeCotjlant, L. Texier et J. David-Chaussé: Un cas d’amyloidose primaire systématisée avec macroglossie, myélomes multiples des os et Proteinurie de Bence-Jones. Bull. Soc. franç. Derm. Syph. (Paris) 58, 245 (1951).
Kernohan, J. W., and H. W. Woltman: Amyloid neuritis. Arch. Neurol. Psychiat. (Chicago) 47, 132 (1942).
Kerwin, A. J.: Idiopathic amyloid disease of the heart. J. Lab. clin. Med. 22, 255 (1936).
King, F. H., and G. D. Oppenheimer: Rupture of amyloid spleen. Ann. intern. Med. 29, 374 (1948).
Königstein, H.: Amyloid der Haut. In Handbuch der Haut- u. Geschlechtskrankheiten, herausgeg. von J. Jadassohn, Bd. 4, Teil 3, 5. 254. Berlin: Springer 1932.
Koletsky, S., and R.M. Stecher: Primary systemic amyloidosis. Involvement of cardiac valves, joints and bones, with pathologic fracture of the femur. Arch. Path. (Chicago) 27, 267 (1939).
Kramer, R., and M. L. Som: Local tumor-like diposits of amyloid in the larynx. Arch. Otolaryng. (Chicago) 21, 324 (1935).
Larsen, R. M.: A pathologic study of primary myocardial amyloidosis. Amer. J. Path. 6, 147 (1930).
Letterer, E.: Neue Untersuchungen Über die Entstehung des Amyloids. Virchows Arch. path. Anat. 293, 34 (1934).
Letterer, E.: Die Amyloidose im Lichte neuer Forschungs-methoden. Dtsch. med. Wschr. 75, 15 (1950).
Lindsay, E.: The heart in primary systemic amyloidosis. Amer. Heart J. 32, 419 (1946).
Lindsay, S., and W. F. Knorp: Primary systemic amyloidosis. Arch. Path. (Chicago) 39, 315 (1945).
Lttbarsch, O.: Zur Kenntnis ungewöhnlicher Amyloidablagerungen. Virchows Arch. path. Anat. 271, 367 (1929).
Magnus-Levy, A.: Amyloidosis in multiple myeloma. J. Mt. Sinai Hosp. 14, 8 (1952).
Marchionini, A.: Nichterbliche Epidermolysis bullosa bei Hautamyloidose. Arch. Derm. Syph. (Berl.) 178, 65 (1938/39).
Marchionini, A., u. F. John: Über lichenoide und poi-kilodermieartige Hautamyloidose. Arch. Derm. Syph. (Berl.) 173, 545 (1935/36).
Marchionini, A., u. F. John: Mass. Gen. Hospital, Weekly clinicopathological exercises. New Engl. J. Med. 245, 736 (1951).
Michelson, H. E., and F. W. Lynch: Systematized amyloidosis of the skin and muscles. Arch. Derm. Syph. (Berl.) 29, 805 (1934);
Michelson, H. E., and F. W. Lynch: Systematized amyloidosis of the skin and muscles. Arch. Derm. Syph. (Berl.) 32, 363 (1935).
Miescher, G.: Beitrag zur Klinik der Paramyloidose (Pseudomyxoedema paramyloidosum). Dermatologica (Basel) 91, 177 (1945).
Navasquez, S. de, and H. A. Treble: A case of primary generalized amyloid disease with involvement of the nerves. Brain 61, 116 (1938).
Nödl, F.: Systematisierte Haut-Muskel-Amyloidose. Arch. Derm. Syph. (Berl.) 198, 319 (1954).
Nomland, R.: Localized (Liehen) amyloidosis of the skin. Arch. Derm. Syph. (Chicago) 33, 85 (1936).
Nomland, R., and F. V. Plummer: Amyloidosis (localized, lichen) of the skin. Arch. Derm. Syph. (Chicago) 29, 470 (1934).
Obiditsch-Mayer, I.: Über einen Fall von Paramyloidose und das Ergebnis der chemischen Analyse desselben. Frankfurt. Z. Path. 57, 492 (1943).
O’Donnell, W. M.: Changing pathogenesis of Addison’s disease with specific reference to amyloidosis. Arch. intern. Med. 86, 266 (1950).
Palitz, L. L., and S. Peck: Amyloidosis cutis: a macular variant. Arch. Derm. Syph. (Chicago) 65, 451 (1952).
Pearson, B., M. M. Rice and K. L. Dickens: Primary systemic Amyloidosis. Arch. Path. (Chicago) 32, 1 (1941).
Pocock, D. S., and J. Dickens: Paramyloidosis with diabetes mellitus and gastrointestinal hemorrhage. New Engl. J. Med. 248, 359 (1953).
Porter, A. D., and L. A. Musso: Localized amyloidosis. The Tenth Internat. Congr. of Dermat., Proceedings. London, 1953, p. 427.
Propp, S., W. B. Scharfman, R. T. Beebe and A. W. Wright: Atypical amyloidosis associated with nonthrombocytopenic purpura and plasmocytic hyperplasia of the bone marrow. Blood 9, 397 (1954).
Randall, O.S.: Multiple myeloma complicated by intestinal obstruction due to amyloid infiltration of the small intestine. Amer. J. Cancer 19, 838 (1933).
Randerath, E.: Über die Morphologie der Paraproteinosen. Verh. dtsch. Ges. Path. 32, 27 (1950).
Reimann, H. A., P. F. Sahyoun and H. T. Chaglassian: Primary amyloidosis. Arch. intern. Med. 93,673 (1954).
Reimann, H. R., and C. M. Eklund: The etiology of amyloid disease with a note on experimental renal amyloidosis. Arch. Path. (Chicago) 21, 1 (1936).
Rigdon, R. H., and F. E. Noblin: Macroglossia accompanying primary systemic amyloidosis. Ann. Otol. (St. Louis) 50, 470 (1949).
Rukavina, J. G., W. D. Block and A. C. Curtis: Familial primary systemic amyloidosis: an experimental, genetic and clinical study. J. invest. Derm. 27, 111 (1956).
Rukavina, J. G., W. D. Block, C. E. Jackson, H. F. Falls, J. H. Carey and A.C. Curtis: Primary systemic amyloidosis: A review and an experimental, genetic, and clinical study of 29 cases with particular emphasis on the familial form. Medicine (Baltimore) 35, 239 (1956).
Schilder, P.: Über die amyloide Entartung der Haut. Frankfurt. Z. Path. 3, 782 (1909).
Siegel, J. M.: Localized cutaneous amyloidosis. Arch. Derm. Syph. (Chicago) 73, 564 (1956).
Soisalo, P., and V. Ritama: Atypical amyloidosis with special consideration of the heart. Acta med. scand. 116, 260 (1944).
Storck, H.: Lichen amyloidosus. Dermatologica (Basel) 108, 409 (1954).
Strauss, A.: Über Paramyloidose. Virchows Arch. path. Anat. 291, 219 (1933).
Strich, S. J., and G. Wade: Primary amyloidosis presenting with peripheral neuritis and intractable heart failure. Lancet 265, 70 (1953).
Tarr, L., and H.W. Ferris: Multiple myeloma associated with nodular deposits of amyloid in muscles and joints. Arch. intern. Med. 64, 820 (1939).
Thingstad, R.: Primary amyloidosis. Acta med. scand. 140, 1 (1951).
Tolone, S., e H. Pansini: Nuovo metodo di produzione dell’ amiloidosi speriomutule. Boll. Soc. ital. Biol. sper. 25, 1008 (1949).
Warren, S.: Generalized amyloidosis of the muscular system. Amer. J. Path. 6, 161 (1930).
Wells, G. C.: Primary systematised amyloidosis with macroglossia. Brit. J. Derm. 64, 169 (1952).
Wessler, S., and A. S. Freedberg: Cardiac amyloidosis: electrocardiographic and pathologic observations. Arch. intern. Med. 82, 63 (1948).
Wiley, A. T., R. R. Teeter and T. G. Schnabel: Rupture of spleen in primary amyloidosis a case. Med. Clin. N. Amer. 35, 1841 (1951).
Woolf, C. R.: Primary systemic amyloidosis with gross cardiac involvement. S. Afr. med. J. 24, 146 (1950).
A, II. Ablagerung von Hyali (S. 58)
Bazex, A.: Un cas de lipoido-protéinose (Maladie de Urbach-Wiethe). Bull. Soc. franç. Derm. Syph. 46, 136 (1939).
Bratjn, W., u. H. Weyhbrecht: Beitrag zur Klinik und Pathogenese der Hyalinosis cutis et mucosae (Lipoid-Proteinose [Wiethe-Urbach]). Arch. Derm. Syph. (Berl.) 194, 538 (1952).
Crawford, G. M.: Lipid proteinosis, generalized. Arch. Derm. Syph. (Chicago) 53, 178 (1946).
Frank, A.: Gastroskopie seltener Magenerkrankungen. Dtsch. Arch. klin. Med. 194, 345 (1949).
Fritze, E., F. v. Zezschwitz u. G. Schulze: Eiweiß-Lipoid-Stoffwechselstö-rungen bei Hyalinosis cutis et mucosae. Klin. Wschr. 28, 435 (1950).
Gerth, H., and H. Flegel: Hyalinosis cutis et mucosae. Derm. Wschr. 133, 10 (1956).
Gottron, H.: Systematisierte Haut-Muskel-Amyloidose unter dem Bilde eines Skleroderma amyloidosum. Arch. Derm. Syph. (Berl.) 166, 584 (1932).
Gottron, H.: Hautveränderungen als Symptome von Stoffwechselkrankheiten. Schriftenreihe der Akademie für ärztliche Fortbildung, Dresden. Herausgeg. von Grote, Bd. 2, S. 217. Dresden: Theodor Steinkopff 1940.
Hänig, E., u. H. Kremer: Bericht Über zwei Fälle von familiärer Hyalinosis cutis et mucosae. Hautarzt 6, 491 (1955).
Hansen, P.: Ein Fall von Lipoidproteinose. Arch. Derm. Syph. (Berl.) 175, 618 (1937).
Hoffmann, E.: Lipoidosis bzw. Xanthodystrophia cutis et mucosae. Derm. Z. 62, 296 (1931).
Holtz, K. H., u. W. Schulze: Beitrag zur Klinik und Pathogenese der Hyalinosis cutis et mucosae (Lipoid-Proteinose Urbach-Wiethe). Arch. Derm. Syph. (Berl.) 192, 206 (1950).
Izaki, M., T. Horiuchi and H. Hozakt: Lipoidosis cutis et mucosae (Lipoidproteinose Urbach-Wiethe): Report of a case. Keiô J. Med. 3, 163 (1954).
Katzenellenbogen, I., and H. Ungar: Lipoid proteinosis (Reinvestigation of a case previous lyreported by Urbach and Wiethe in 1929). Dermatologica (Basel) 115, 23, (1957).
Laymon, C. W., and E. M. Hill: An appraisal of hyalinosis cutis et mucosae. Arch. Derm. Syph. (Chicago) 75, 55 (1957).
Lever, W. F., E. L. Schultz and N. A. Hurley: Plasma proteins in various diseases of the skin. A.M.A. Arch. Derm. Syph. 63, 702 (1951).
Lundt, V.: Beitrag zur Kenntnis der Hyalinosis cutis et mucosae. Arch. Derm. Syph. (Berl.) 188, 128 (1949).
Miedzinski, F., u. J. Kozakiewicz: Zur Kenntnis der Hyalinosis cutis et mucosae. Dermatologica (Basel) 114, 106 (1957).
Montgomery, H.: Lipid proteinosis. Arch. Derm. Syph. (Chicago) 58, 625 (1948).
Montgomery, H., and F. Z. Havens: Xanthomatosis. IV. Lipoid proteinosis (phosphatide lipoidosis). Arch. Otolaryng. (Chicago) 29, 650 (1939).
Price, H., W. V. La Rosa and E. B. Settle: Lipoidosis cutis et mucosae. Report of a case. Arch. Derm. Syph. (Chicago) 55, 42 (1947).
Ramos e Silva, J.: Lipid proteinosis (Urbach-Wiethe). Arch. Derm. Syph. (Chicago) 47, 301 (1943).
Rothman, S.: In der Diskussion zu Montgomery, H.: Lipid proteinosis. Arch. Derm. Syph. (Chicago) 58, 625 (1948).
Schwab, W., u. W. Braun: Zur Klinik und Pathogenese der Hyalinosis cutis et mucosae. Arch. Ohr.-, Nas.- u. Kehlk.-Heilk. 162,141 (1952).
Sulzberger, M. B.: A case of lipoidosis cutis et mucosae: so-called ”lipoid proteinosis”, Urbach-Wiethe. Laryngoscope (St. Louis) 52, 286 (1942).
Szodoray, L.: Über die Lipoidproteinose (lipoidosis cutis et mucosae) Urbach-Wiethe. Dermatologica (Basel) 83, 375 (1941).
Theissing, G., u. W. Schmidt: Hyalinosis cutis et mucosae. Z. Laryng. 33, 66 (1954).
Tripp, R. N.: Lipoidosis cutis et mucosae. N.Y. St. J. Med. 36, 619 (1936).
Ungar, H., and I. Katzenellenbogen: Hyalinosis of skin and mucous membranes (Urbach-Wiethe’s lipoid proteinosis). Arch. Path. (Chicago) 63, 65 (1957).
Urbach, E.: Lipoidproteinose (Lipoidosis cutis et mucosae). In Handbuch der Haut- und Geschlechtskrankheiten, herausgeg. von J. Jadassohn, Bd. 12, Teil 2, S. 335. Berlin: Springer 1932.
Urbach, F., and M. Gray: Lipoid proteinosis. Arch. Derm. Syph. (Chicago) 70, 687 (1954).
Weyhbrecht, H., u. G. W. Körting: Zur Pathogenese der Hyalinosis cutis et mucosae. Arch. Derm. Syph. (Berl.) 197, 459 (1954).
Wiethe, C.: Über lokale Hyalinablagerungen in den oberen Luftwegen. Acta oto-laryng. (Stockh.) 10, 237 (1926).
Wile, J., and J. S. Snow: Lipoid proteinosis. Report of a case. Arch. Derm. Syph. (Chicago) 43, 134 (1941).
Wise, F., and C. R. Rein: Lipoidosis cutis et mucosae (Lipoid-proteinosis of Urbach). Arch. Derm. Syph. (Chicago) 37, 201 (1938).
A, III. Ablagerung von Mucin (S. 68)
Amersbach, J. C., and B. Kanee: Localized myxedema in association with hyperthyroidism. Arch. Derm. Syph. (Chicago) 49, 415 (1944).
Anderson, H., G. Asboe-Hansen, F. Quaade and R. Wichmann: Skin biopsy and thyrotrophin assay in children with endocrine disorders, especially hypothyroidism. Acta endocr. (Kbh.) 18, 557 (1955).
Arzt, L.: Zur Frage des lokalen Myxödems bei Basedow. Med. Klin. 30, 49 (1934).
Asboe-Hansen, G.: Hyaluronidase action on the permeability of human skin. Acta derm.-venereol. (Stockh.) 30, 27 (1950) (I).
Asboe-Hansen, G.: The variability in the hyaluronic acid content of the dermal connective tissue under the influence of thyroid hormone. Acta derm.-venereol. (Stockh.) 30, 221 (1950) (II).
Asboe-Hansen, G.: The intercellular substance of the connective tissue in myxedema. J. Invest. Dermat. 15, 25 (1950) (III).
Asboe-Hansen, G., K. Iversen and R. Wichmann: Malignant exophthalmos. Muscular changes and thyrotrophin content in serum. Acta endocr. (Kbh.) 11, 376 (1952).
Bahner, F., u. A. Weygand: Das Verhalten des thyreotropen Hormons beim spontanen Myxödem. Dtsch. Arch. klin. Med. 193, 288 (1947/48).
Bernhardt, R.: Myxoedema papulatum et tuberosum. Zur Frage des Liehen ruber monileformis Kaposi. Arch. Derm. Syph. (Berl.) 164, 689 (1932).
Bishopric, G. A., N. H. Garrett and W. N. Nicholson: Clinical value of the TSH in the diagnosis of thyroid disease. Amer. J. Med. 18, 15 (1955).
Blaich, W.: In der Diskussion zu L.Halter: Skleroedema adultorum (Buschke). Derm. Wschr. 124, 968 (1951).
Bloom, D., F. J. Herrmann and H. Sharlit: Local injections of a preparation of hyaluronidase in the treatment of mucinous infiltration of the skin. J. invest. Derm. 12, 339 (1949).
Bloomer, H. A., and L. H. Kyle: Myxedema. A.M.A. Arch. intern. Med. 104, 234 (1959).
Bollet, A. J., N. F. Boas and J. J. Bunim: Synthesis of hexos-amine by connective tissue (in vitro). Science 120, 348 (1954).
Braun-Falco, O.: Neueres zur Histopathologie des Scleroedema adultorum (Buschke). Derm. Wschr. 125, 409 (1952).
Braun-Falco, O.: Histochemische und morphologische Studien an normaler und pathologisch veränderter Haut. Arch. Derm. Syph. (Berl.) 198, 111 (1954) (I).
Braun-Falco, O.: In der Diskussion zu Landes, E.: 2 Fälle von Myxoedema circumscriptum tuberosum. Derm. Wschr. 130, 1130 (1954) (II). —
Braun-Falco, O.: Zum Formenkreis der Myxodermien. Derm. Wschr. 133, 540 (1956).
Breinin, G. M.: Scleredema adultorum (ocular manifestations). Arch. Ophthal. (Chicago) 50, 155 (1953).
Butler, J., and C. W. Laymon: Nodular diffuse scleroderma. Arch. Derm. Syph. (Chicago) 35, 919 (1937).
Carol, W. L. L.: Über atypisches Myxödem. Acta derm.-venereol. (Stockh.) 13, 127 (1932).
Cawley, E. P., C. H. Lupton, C. E. Wheeler and J. F. A. McManus: Examination of normal and myxedematous skin. A.M.A. Arch. Derm. 76, 537 (1957).
Cohen, E. L.: Myxoedema circumscriptum thyrotoxicum. Brit. J. Derm. 58, 173 (1946).
Curtis, A. C., E. P. Cawley and E. B. Johnwick: Association of progressive (malignant) exophthalmos and localized myxedema. Arch. Derm. Syph. (Chicago) 60, 318 (1949).
Dalton, J. E., and M. A. Seidell: Studies on lichen myxedematosus (papular mucinosis). Arch. Derm. Syph. (Chicago) 67, 194 (1953).
D’Angelo, S. A., K. E. Paschkis, A. E. Gordon and A. Cantarow: Thyroid-thyrotropic hormone balance in the blood of normal and endocrinopathic individuals. J. clin. Endocr. 11, 1237 (1951).
De Robertis, E.: Assay of thyrotropic hormone in human blood. J. clin. Endocr. 8, 956 (1948).
Dobyns, B. M.: Present concepts of the pathologic physiology of exophthalmos. J. clin. Endocr. 10, 1202 (1950).
Dobyns, B. M., and S. L. Steelman: The thyroid stimulating hormone of the anterior pituitary as distinct from the exophthalmos producing substance. Endocrinology 52, 705 (1953).
Dobyns, B. M., and L. A. Wilson: An exopthalmos-producing substance in the serum of patients suffering from progressive exophthalmos. J. clin. Endocrin. 14, 1343 (1954).
Dössekker, W.: Über einen Fall von atypischem tuberösem Myxödem. Arch. Derm. Syph. (Berl.) 123, 76 (1916).
Dubreuilh, W.: Fibromes müiaires; sclérodermic consécutive. Ann. Derm. Syph. (Paris) 7, 569 (1906).
Duran-Reynals, F., H. Bunting and G. van Wagenen: Studies on the sex skin of Macaca mulatta. Ann. N.Y. Acad. Sci. 52, 1006 (1950).
Eberhartinger, C.: Ein Fall von Myxoedema circumscriptum symmetricum crurum. Wien. med. Wschr. 106, 449 (1956).
Ehrmann, S., u. St. R. Brünauer: Scleroedema adultorum (Buschke). In Handbuch der Haut- und Geschlechtskrankheiten, herausgeg. von J. Jadassohn, Bd. VIII/2, S. 875. Berlin: Springer 1931.
Epstein, N. N.: Scleredema adultorum (Buschke). J. Amer. Med. Ass. 99, 820 (1932).
Epstein, N. N.: In der Diskussion zu S. E. Sweitzer u. C. W. Laymon: Scleredema adultorum (Buschke). Arch. Derm. Syph. (Chicago) 37, 420 (1938).
Escamilla, R. F.: Why is there no elevation of the plasma cholesterol level in pituitary myxedema ? J. clin. Endocr. 13, 746 (1953).
Fischer, F. v.: Beitrag zur Klinik und Pathogenese des Myxoedema tuberosum. Derma-tologica (Basel) 98, 270 (1949).
Forsey, R. R., and A. W. Anhalt: Hydrocortisone in the treatment of localized Myxedema. A.M.A. Arch. Derm. 74, 352 (1956).
Frank, L. J.: Scleredema adultorum (Buschke). Report of case involving the tongue. Arch. Derm. Syph. (Chicago) 36, 1052 (1937).
Freudenthal, W.: Myxoedema circumscriptum. Proc. roy. Soc. Med. 40, 258 (1947).
Freund, H.: Über Sclerödem (Buschke), unter besonderer Berücksichtigung der Histologie. Arch. Derm. Syph. (Berl.) 161, 92 (1930).
Gabrilove, J. L., and A. W. Ludwig: The histogenesis of myxedema. J. clin. Endocr. 17, 925 (1957).
Galewsky, E. E.: Sklerodermieartige Erkrankung bei Hyperthyreoidose. VIII. Congr. Internat, de Dermatologie et de Syphiligraphie, Copenhagen, 5–9 Août 1930. Copenhagen, Engelsen u. Schroeder, 1931, p. 540, pp. 690–693, p. 1215.
Gedda, P. O., and M. Lindgren: The hyperophthalmopathic type of Graves’ disease. Acta med. scand. 148, 385 (1954).
Gersh, I., and H. R. Catchpole: The organization of ground substance and basement membrane and its significance in tissue injury, disease and growth. Amer. J. Anat. 85, 457 (1949).
Gottron, H. A.: Scleroedema adultorum (Buschke). Zbl. Haut- u. Geschl.-Kr. 65, 129 (1940).
Gottron, H. A.: Skleromyxödem. Arch. Derm. Syph. (Berl.) 199, 71 (1954).
Gottron, H. A., u. G. W. Körting: Zur Pathogenese des Myxoedema circumscriptum tuberosum. Arch. Derm. Syph. (Berl.) 195, 625 (1953).
Gougerot, H., et A. Carteaud: Myxoedème lichénoide. Bull. Soc. franç, derm. syph. 40, 732 (1933).
Grais, M. L.: Local injections of a preparation of hyaluronidase in the treatment of localized (pretibial) myxedema. J. invest. Derm. 12, 345 (1949).
Hamminga, H., u. F. J. Keuning: Lichen myxoedematosus (mucinosis papulosa cutis). Dermatologica (Basel) 109, 86 (1954).
Hektoen, L.: Hyperplastic persistent thymus in exophthalmic goitre. Int. Med. Magazine 4, 584 (1895).
Hertz, S., and E. G. Oastler: Assay of blood and urine for thyrotropic hormone in thyrotoxicosis and myxedema. Endocrinology 20, 520 (1936).
Ingram, J. T.: Circumscribed myxoedema associated with hyperthyroidism. Brit. J. Derm. 45, 19 (1933).
Iversen, K., and G. Asboe-Hansen: Studies on the fat-mobilizing factor of the anterior pituitary gland. Acta endocr. (Kbh.) 11, 111 (1952).
Jaksch, B. v.: Fall von Morbus Basedowii. Prag. med. Wschr. 17, 602 (1892).
Jefferies, W. M.: Studies of the relationship of the thyrotropic, exophthalmic and fat-mobilizing principles of pituitary extract. II. The effect of iodination of pituitary extract upon these three principles. J. clin. Endocr. 9, 927 (1949).
Kaposi, M.: Lichen ruber moniliformis. Vjschr. Derm. 13, 571 (1886).
Keining,E.: Das atypische Myxödem der Haut. Derm. Wschr. 88, 243 (1929).
Keining, E., u. O. Braun-Falco: Zur Klinik und Pathogenese des Skleromyxoedems. Acta derm.-venereol. (Stockh.) 36, 37 (1956).
Reining, E., u. G. Dorner: Rascher Behandlungserfolg mit Penicillin bei Skleroedema adultorum. Hautarzt 1, 231 (1950).
Kircher, W.: Skierödem (Buschke) bei einem Kleinkinde. Arch. Kinderheilk. 141, 148 (1951).
Ronrad, J., u. A. Winkler: Skleromyxödem (Arndt-Gottron). Arch. klin. exp. Derm. 202, 254 (1956).
Rreibich, C.: Liehen sclerosus. Arch. Derm. Syph. (Berl.) 124, 589 (1917/18).
Rreibich, C.: Muzinöse Bindegewebsdegeneration in der Haut (Färbung im Paraffinschnitt). Derm. Wschr. 71, 539 (1920).
Rreibich, C.: Mucin bei Hauterkrankung. Arch. Derm. Syph. (Berl.) 150, 243 (1926).
Rreibich, C.: Mucin bei Hauterkrankung. IL Mitteilung. Arch. Derm. Syph. (Berl.) 153, 799 (1927).
Labhart, A.: Die Schilddrüse. In Labhart, A.: Rlinik der Inneren Sekretion, S. 147. Berlin-Göttingen-Heidelberg: Springer 1957.
Landes, E.: 2 Fälle von Myxoedema circumscriptum tuberosum. Derm. Wschr. 130, 1138 (1954).
Langer, E., u. W. Pürschel: Myxomatosis cutis papulosa. Z. Haut- u. Geschl.-Kr. 13, 235 (1952).
Leinwand, I.: Generalized scleredema; report with autopsy findings. Ann. intern. Med. 34, 226 (1951).
Levee, W. F.: Bestimmung der Lipoproteine und Glykoproteine im Plasma von Patienten mit verschiedenen Hautkrankheiten. Hautarzt 4, 426 (1953).
Lewtschenkow, D. D. v.: Ein seltener Fall von myxomatöser Hautdegeneration. Mh. prakt. Derm. 50, 239 (1910).
Ludwig, A. W., N. F. Boas and L. J. Soffer: Role of mucopolysaccharides in pathogenesis of experimental exophthalmos. Proc. Soc. exp. Biol. (N.Y.) 73, 137 (1950).
Madison, L. L.: Scleredema. Amer. J. Med. 9, 707 (1950).
Mancini, R. E., J. C. Gaeberi and F. A. de la Balze: Serum mucoprotein and mucoproteins of connective tissue of the skin in generalized myxedema. J. clin. Endocr. 12, 931 (1952).
Marchionini, A., u. D. Jahn: Elephantiastisches tuberöses Myxoedema circumscriptum bei Morbus Basedow. Arch. Derm. Syph. (Berl.) 176, 694 (1938).
McCtjistion, C. H., and E. P. Schoch Jr.: Autopsy findings in lichen myxedematosus. A.M.A. Arch. Derm. 74, 259 (1956).
Means, J. H.: Hyperophthalmopathic Graves’ disease. Ann. intern. Med. 23, 779 (1945).
Meyer, K., and E. Chaffee: The mucopolysaccharides of skin. J. biol. Chem. 138, 491 (1941).
Millee, T. H., and C. Moppee: Lichen myxedematosus. A.M.A. Arch. Derm. Syph. 71, 542 (1955).
Montgomeey, H., and L. J. Undeewood: Lichen myxedematosus (differentiation from cutaneous myxedemas or mucoid states). J. invest. Derm. 20, 213(1953).
Moerow, H.: Symmetrical areas of solid oedema occurring in Graves’s disease. Brit. J. Derm. 11, 286 (1899).
Mumford, P. B., and H. W. Barber: Lichen ruber moniliformis (Morbus moniliformis lichenoides: Wise and Rein; Myxoedema moniliforme: Freudenthal). Proc. roy. Soc. Med. 36, 286 (1943).
Mustacchi, P., M. L. Petermann and J. E. Rall: Changes in human plasma mucoproteins in hyperthyroidism and myxedema. J. clin. Endocr. 14, 729 (1954).
Neumann, H.: Die Schleimpapel-Krankheit (Lichen myxoedematosus). Derm. Wschr. 101, 1263 (1935).
O’Leary, P. A.: Localized solid edema of the extremities in association with exophthalmic goiter. Arch. Derm. Syph. (Chicago) 21, 57 (1930).
O’Leary, P. A., M. Waisman and M. W. Harrison: Scleredema adultorum. Amer. J. Med. Sci. 199, 458 (1940).
Palitz, L. L., and M. J. Brtjnner: The mucinoses. A classification with histochemical studies on the nature of mucin. J. invest. Derm. 14, 159 (1950).
Per, M. L., u. N. L. Rossiansky: Ein Beitrag zur Frage des atypischen tuberösen Myxödems (Jadassohn-Dössekker). Arch. Derm. Syph. (Berl.) 156, 320 (1928).
Pillsbury, D. M., W. B. Shelley and A. M. Kligman: Dermatology, p. 905. Philadelphia: W.B.Saunders Company 1956.
Pillsbury, D. M., and J. H. Stokes: Circumscribed myxedema of the skin. Arch. Derm. Syph. (Chicago) 24, 255 (1931).
Purves, H. D., and W. E. Griesbach: Thyrotropic hormone in thyrotoxicoses, malignant exophthalmos and myxoedema. Brit. J. exp. Path. 30, 23 (1949).
Rawson, R. W., G. D. Sterne and J. C. Aub: Physiological reactions of the thyroid-stimulating hormone of the pituitary. Endocrinology 30, 240 (1942).’
Reitmann, K.: Über eine eigenartige, der Sklerodermie nahestehende Affektion. Arch. Derm. Syph. (Berl.) 92, 417 (1908).
Reuter, M. J.: Histopathology of the skin in myxedema. Arch. Derm. Syph. (Chicago) 24, 55 (1931).
Richter, W.: Über lokales Myxödem der Haut, mit Beziehung zum Basedow. Derm. Wschr. 84, 7, 51 (1927).
Richter, W.: Beitrag zu dem lokalen Myxödem bei Basedow. Arch. Derm. Syph. (Berl.) 164, 100 (1931).
Savitt, L. E.: Injection of hydrocortisone into dermatologie lesions. A.M.A. Arch. Derm. 76, 780 (1957).
Schnitzer, A.: Über zwei Fälle von Skleroedema adultorum. Dermato-logica (Basel) 84, 215 (1941).
Schtjermann, H.: Über Hauterscheinungen mit Beziehung zu Myxödem und Basedowscher Krankheit. Arch. Derm. Syph. (Berl.) 176, 544 (1938).
Schwartz, H. J., and R. F. Madden: Circumscribed myxedema. Arch. Derm. Syph. (Chicago) 43, 375 (1941).
Smelser, G. K., and M. S. Ozanics: Studies on the nature of the exophthalmos-producing principle in pituitary extracts. Amer. J. Ophthal. 38, 107 (1954).
Strandberg, J.: Haut und innere Sekretion. Die Schilddrüse. In J. Jadassohns Handbuch der Haut- und Geschlechtskrankheiten, Bd. III, S. 178. Berlin: Springer 1929.
Sweitzer, S. E., and C. W. Laymon: Scleredema adultorum (Buschke). Arch. Derm. Syph. (Chicago) 37, 420 (1938).
Tappeiner, J.: Zur Pathogenese des Liehen myxoedematosus. (Mucinosis papulosa cutis.) Arch. klin. exp. Derm. 201, 160 (1955).
Trotter, W. R., and K. C. Eden: Localized preti-bial myxoedema in association with toxic goitre. Quart. J. Med. 11, 229 (1942).
Tryb, A.: Über eine seltene Erkrankung der Haut mit Schleimanhäufungen. Arch. Derm. Syph. (Berl.) 143, 428 (1923).
Vallee, B. L.: Scleredema: a systemic disease. New Engl. J. Med. 235, 207 (1946).
Vilanova, X., and J. M. Canadell: Myxedema circumscriptum thyrotoxicum. J. clin. Endocr. 9, 883 (1949).
Waddington, E.: Prätibiales Myxödem. Derm. Wschr. 128, 841 (1953).
Watson, E. M.: Localized (pretibial) myxoedema associated with Graves’ disease. Canad. med. Ass. J. 54, 260 (1946).
Watson, E. M., and R. H. Pearce: The mucopolysaccharide content of the skin in localized (pretibial) myxedema. Amer. J. clin. Path. 17, 507 (1947) (I).
Watson, E. M., and R. H. Pearce: The biochemistry of the skin: a review; with particular reference to the mucopolysaccharides. Brit. J. Derm. 59, 327 (1947) (II).
Watson, E. M., and R. H. Pearce: The mucopolysaccharide content of the skin in localized (pretibial) myxedema. Amer. J. clin. Path. 19, 442 (1949).
Watson-Williams, P.: A case of Graves’ disease. Clin. J. 7, 92 (1895/96).
Wiener, R.., A. Iannaccone, J. Eisenberg, S.I. Griboff, A. W. Ludwig and L.J. Soffer: Influence of hormone therapy on body fluids, electrolyte balance and mucopolysaccharides in myxedema. J. Clin. Endocr. 15, 1131 (1955).
Wile, U.J.: Localized myxedema. Arch. Derm. Syph. (Chicago) 36, 911 (1937).
Winer, L. H., u. E. T. Wright: Muzin. Eine vergleichende Studie histopatholo-gischer Farbreaktionen. Derm. Wschr. 140, 1281 (1959).
Wise, F., and C. R. Rein: Lichen ruber moniliformis (morbus moniliformis lichenoides). Arch. Derm. Syph. (Chicago) 34, 830 (1936).
Wodniansky, P.: Über die Ätiologie und Pathogenese des Myxoedema circumscriptum praetibiale symmetricum. Arch. klin. exp. Derm. 205, 22 (1957).
B, I. Systemische Lipoidosen mit erhöhten Serumlipoidwerten (S. 87)
Abegg, W.: Ein Fall von hochgradiger alimentärer „hepatogener“ Fettretention im Blut bei einem 11jährigen Kinde. Jb. Kinderheilk. 149, 94 (1937).
Achor, R. W., R. K. Winkelmann and H. O. Perry: Cutaneous side effects from use of triparanol (MER-29): Preliminary data onichthyosis and loss of hair. Proc. Mayo Clin. 36,217 (1961).
Adlersberg, D.: Inborn errors of lipid metabolism. Arch. Path. (Chicago) 60, 481 (1955).
Adlersberg, D.: Hormonal influences on the serum lipids. Amer. J. Med. 23, 769 (1957).
Ahrens Jr., E. H., J. Hirsch, W. Insull Jr., T. T. Isaltas, R. Blomstrand and M. L. Peterson: Dietary control of serum lipids in relation to atherosclerosis. J. Amer. med. Ass. 164, 1905 (1957).
Ahrens, Jr., E. H., and H. G. Kunkel: The relationship between serum lipids and skin xanthomata in eighteen patients with primary biliary cirrhosis. J. clin. Invest. 28, 1565 (1949).
Ahrens Jr., E. H., M. A. Payne, H. G. Kunkel, W. J. Eisenmenger and S. M. Blondheim: Primary biliary cirrhosis. Medicine (Baltimore) 29, 299 (1950).
Arndt, G.: Kongenitales familiäres Xanthom (flach, tuberös, geschwulstartig). Derm. Z. 39, 89 (1923).
Bernstein, S. S., H. H. Williams, F. C. Hummel, M. D. Shepherd and B. N. Erickson: Metabolic observations on a child with essential hyperlipemia. J. Pediat. 14, 570 (1939).
Best, M. M., C. H. Duncan, E. J. van Loon and J. D. Wathen: The effects of sitosterol on serum lipids. Amer. J. Med. 19, 61 (1955).
Beumer, H.: Cholesterinstoff Wechsel bei Glykogenose. Münch. med. Wschr. 84, 1007 (1937).
Bevans, M., and W. H. Batchelor: Cholangitic cirrhosis with intrahepatic biliary tract obstruction and xanthomatosis. Amer. J. Med. 9, 133 (1950).
Beveridge, J. M. R., W. F. Connell, G. Mayer, J. B. Firstbrook and M. de Wolfe: Effects of certain vegetable and animal fats on plasma lipids of humans. Circulation 10, 593 (1954).
Bloom, D., S. R. Kaufman and R.A. Stevens: Hereditary xanthomatosis. Arch. Derm. Syph. (Chicago) 45, 1 (1942).
Bloomfield, A. L., and B. Shenson: The syndrome of idiopathic hyperlipemia with crises of violent abdominal pain. Stanford Med. Bull. 5, 185 (1947).
Bloor, W. R., K. F. Pelkan and D. M. Allen: Determination of fatty acids (and cholesterol) in small amounts of blood plasma. J. biol. Chem. 52, 191 (1922).
Boggs, J. D., D. Y. Hsia, R. F. Mais and J. A. Bigler: The genetic mechanism of idiopathic hyperlipemia. New Engl. J. Med. 257, 1101 (1957).
Bozian, R. C., I. J. Laufer, L. J. Stutman, K. Hirschhorn and C. F. Wilkinson Jr.: Clinical studies with unsaturated fats in patients with hypercholesterolemia and hyperlipemia. Circulation 16, 494 (1957).
Bragdon, J. H., and R. S. Gordon Jr.: Tissue distribution of C14 after the intravenous injection of labeled chylomicrons and unesterified fatty acids in the rat. J. clin. Invest. 37, 574 (1958).
Brehmer, W., u. P. Lubbers: Über eine generalisierte Xanthomatose mit Knochenbefall und diffuser Plasmazellwucherung im Knochenmark bei essentieller Hyperlipämie. Virchows Arch. path. Anat. 318, 394 (1950).
Bronte-Stewart, B., A. An-tonis, L. Eales and J. F. Brock: Effects of feeding different fats on serum-cholesterol level. Lancet 19561, 521.
Brunner, W.: Beitrag zur pankreatogenen Lipämie. Klin. Wschr. 14, 1853 (1935).
Bruton, O. C., and A. J. Kanter: Idiopathic familial hyperlipemia. Amer. J. Dis. Child. 82, 153 (1951).
Bürger, M., u. O. Grütz: Über hepatosplenomegale Lipoidose mit Xanthomatosen Veränderungen in Haut und Schleimhaut. Arch. Derm. Syph. (Berl.) 166, 542 (1932).
Bürger, M., W. Schrade u. H. Landers: Die diätetische Beeinflussung des Stoffwechsels bei hepatosplenomegaler Lipoidose. Z. klin. Med. 132, 594 (1937).
Chanutin, A., and S. Ludewig: Blood lipid studies in a case of xanthomatosis associated with hepatic damage. J. Lab. clin. Med. 22, 903 (1937).
Chapman, F. D., and T. D. Kinney: Hyperlipemia. ”Idiopathic hyperlipemia”. Amer. J. Dis. Child. 62, 1014 (1941).
Christie, J. F., A. Lyall and T. E. Anderson: Case of xanthoma multiplex associated with hypothyroidism. Brit. J. Derm. 42, 429 (1930).
Cohn, E. J., F. R. N. Gurd, D. M. Surgenor, B. A. Barnes, R. K. Brown, G. Derouaux, J. M. Gillespie, F. W. Kahnt, W. F. Lever, C. H. Liu, D. Mittelman, R. F. Mouton, K. Schmid and E. Uroma: A system for the separation of the components of human blood: Quantitative procedures for the separation of the protein components of human plasma. J. Amer. chem. Soc. 72, 465 (1950).
Collett, R. W., and R. L. J. Kennedy: Chronic relapsing pancreatitis associated with hyperlipemia in an eight year old boy. Proc. Mayo Clin. 23, 158 (1948).
Combes, F. C., and H. T. Behrman: Xanthoma eruptivum (xanthoma diabeticorum). Arch. Derm. Syph. (Chicago) 43, 927 (1941).
Cook, C. D., H.L. Smith, C. W. Giesen and G. L. Berdez: Xanthoma tuberosum, aortic stenosis, coronary sclerosis and angina pectoris. Report of a case in a boy thirteen years of age. Amer. J. Dis. Child. 73, 326 (1947).
Corazza, L. J., and R. M. Myerson: Essential hyperlipemia. Report of four cases, with special reference to abdominal crises. Amer. J. Med. 22, 258 (1957).
Corday, E., H. Jaffe and D. W. Irving: Hypercholesteremic effect of tetraiodothyroformic acid on brittle coronary patients. Arch. intern. Med. 106, 809 (1960).
Cornbleet, T.: Local action of heparin on xanthomas. A.M.A. Arch. Derm. Syph. 71, 172 (1955).
Craig, L. S., M. Lisser and M. H. Soley: Report of two cases of myxedema with extreme hypercholesteremia; one complicated by xanthoma tuberosum. J. clin. Endocr. 4, 12 (1944).
Crocker, A. C.: Skin xanthomas in childhood. Pediatrics 8, 573 (1951).
Crofford, O. B., J. G. Coniglio, H. C. Meng and E. V. Newman: Demonstration of the specifio metabolic defect in primary essential hyperlipemia with secondary diabetes. J. clin. Invest. 37, 886 (1958).
Curtis, A. C., and H. C. Blaylock: Secondary eruptive xanthomatosis due to myxedema. Arch. Derm. Syph. (Chicago) 66, 460 (1952).
Edelstein, A. J., C. A. Beerman and R. C. Greene: Secondary eruptive xanthoma and nevus unius lateris with lipoid nephrosis. A.M.A. Arch. Derm. 72, 275 (1955).
Farquhar, J. W., and M. Sokolow: A comparison of the effects of β-Sitosterol and saff-flower oil, alone and in combination, on serum lipoids of humans: a long-term study. Circulation 16, 494 (1957).
Fekete, L. L., W. F. Lever and E. Klein: Inhibition of lipemia clearing activity by human white blood cells and platelet components. J. Lab. clin. Med. 52, 680 (1958).
Frank, L., and L. M. Levitt: Idiopathic hyperlipemia with secondary xanthomatosis. A.M.A. Arch. Derm. Syph. 64, 434 (1951).
Geyer, R. P., G. V. Mann and F. J. Stare: The turbimetric determination of infused fat in blood after the intravenous administration of fat emulsions. J. Lab. clin. Med. 33, 175 (1948).
Gierke, E.V.: Hepato-nephromegalia glycogenica (Glykogenspeicherkrank-heit der Leber und der Nieren). Beitr. path. Anat. 82, 497 (1929).
Gitlin, D., and D. Cornwell: Plasma lipoprotein metabolism in normal individuals and in children with the nephrotic syndrome. J. clin. Invest. 35, 706 (1956).
Gofman, J. W., L. Rubin, J. P. McGinley and H. B. Jones: Hyperlipoproteinemia. Amer. J. Med. 17, 514 (1954).
Gordon, R. S., E. Boyle, R. K. Brown, A. Cherkes and C. B. Anfinsen: Role of serum albumin in lipemia clearing reaction. Proc. Soc. exp. Biol. (N.Y.) 84, 168 (1953).
Gottron, H.A.: Disseminierte Xanthelasmen (Xanthome) bei Diabetes mellitus mit hochgradigster Hyperlipämie. Derm. Z. 66, 176 (1933).
Gottron, H.A.: Hautkrankheiten unter dem Gesichtspunkt der Vererblichkeit. In: Wer ist erbgesund und wer ist erbkrank? Herausgeg. von W. Klein, S. 191. Jena: Gustav Fischer 1935.
Gottron, H.A.: Schüller-Christiansche Krankheit unter besonderer Berücksichtigung der Hautveränderungen. Arch. Derm. Syph. (Berl.) 182, 691 (1942).
Gould, R. G., C. B. Taylor, J. E. Hagerman, I. Warner and D. J. Campbell: Cholesterol metabolism. I. Effect of dietary cholesterol on the synthesis of cholesterol in dog tissue in vitro. J. biol. Chem. 201, 519 (1953).
Grossman, M. I.: The quantitative measurement of heparin-induced lipemia clearing activity of plasma. J. Lab. clin. Med. 43, 445 (1954).
Haensch, R.: Der Heparin-Effekt auf das Lipoidelektrophorese-Diagramm bei idiopathischer hyperlipidämischer Xanthomatose. Arch. klin. exp. Derm. 205, 413 (1957).
Haensch, R.: Heparin-Therapie und Klinik der idiopathischen hyperlipidämischen Xanthomatose. Arch. klin. exp. Derm. 205, 512 (1958).
Harris-Jones, J. N., E. G. Jones and P. G. Wells: Xanthomatosis and essential hypercholesterolaemia. Lancet 272, 855 (1957).
Hartmann, G.: Die sogenannte Xanthomatöse biliäre Cirrhose und die chronische pseudoxanthomatöse Pericholangitis. Frankfurt. Z. Path. 68, 55 (1957).
Hashim, S. A., and T. B. van Itallie: Use of bile acid sequestrant in treatment of pruritus associated with biliary cirrhosis. J. invest. Derm. 35, 253 (1960).
Havel, R. J., and R. S. Gordon Jr.: Idiopathic hyperlipemia: metabolic studies in an affected family. J. clin. Invest. 39, 1777 (1960).
Herbst, F. S. M., and N. A. Hurley: Effects of heparin on alimentary hyperlipemia. An electrophoretic study. J. clin. Invest. 33, 907 (1954).
Herbst, F. S. M., W. F. Lever and N. A. Hurley: Idiopathic hyperlipemia and primary hypercholesteremic xanthomatosis. VI. Studies of the serum proteins and lipoproteins by moving boundary electrophoresis and paper electrophoresis before and after administration of heparin. J. invest. Derm. 24, 507 (1955).
Heymann, W., and E. C. Clark: Pathogenesis of nephrotic hyperlipemia. Amer. J. Dis. Child. 70, 74 (1945).
Hicks, J. H., and J. F. Mullins: Pruritus of liver disease (xanthomatous biliary cirrhosis). A. M. A. Arch. Derm. Syph. 71, 46 (1955).
Hollett, C., and H. C. Meng: Lipemia clearing factor inhibitor in normal plasma. Fed. Proc. 16, 60 (1957).
Hollister, L. E., and S. L. Kanter: Essential hyperlipemia treated with heparin and with chlorpromazine. Gastro-enterologia (Basel) 29, 1069 (1955).
Holt, L. E., F. X. Aylward and H. G. Timbres: Idiopathic familial lipemia. Bull. Johns Hopk. Hosp. 64, 279 (1939).
Hopgood, W. C.: Idiopathic hyperlipemia. New Engl. J. Med. 238, 429 (1948).
Joel, E.: Zur Klinik der Lipämie. Z. klin. Med. 100, 46 (1924).
Jones, H. B., J. W. Gofman, F. T. Lindgren, T. P. Lyon, D. M. Graham, B. Strisower and A. V. Nichols: Lipoproteins in atherosclerosis. Amer. J. Med. 11, 358 (1951).
Kalkoff, K. W.: Xanthoma planum et tuberosum partim striatim bei biliärer xantho-matöser Cirrhose. Hautarzt 2, 536 (1951).
Kinsell, L. W., and G. D. Michaels: Letter to the editor. Amer. J. clin. Nutr. 3, 247 (1955).
Kinsell, L. W., G. D. Michaels and J. P. Dailey: Effects of ethyl linoleate, ethyl oleate, trilinolein, triolein and of a phosphatide mixture containing tetranoic acid, upon fatty acid composition of plasma lipids in normal and abnormal subjects. Circulation 16, 479 (1957).
Kinsell, L. W., J. Partridge, L. Boling, S. Margen and G. D. Michaels: Dietary modification of serum cholesterol and phospholipid levels. J. clin. Endocr. 12, 909 (1952).
Klatskin, G., and M. Gordon: Relationship between relapsing pancreatitis and essential hyperlipemia. Amer. J. Med. 12, 3 (1952).
Klein, E., and W. F. Lever: Inhibition of lipemia clearing activity by serum of patients with hyperlipemia. Proc. Soc. exp. biol. (N.Y.) 95, 565 (1957).
Klein, E., W. F. Lever, and L. Fekete: Inhibition of lipemia clearing by tissue extracts. Proc. Soc. exp. Biol. (N.Y.) 98, 658 (1958).
Klein, E., W. F. Lever, and L. Fekete: Defective lipemia clearing response to heparin in idiopathic hyperlipemia. J. invest. Derm. 33, 91 (1959).
Korn, E. D.: Clearing f actor, a heparin-activated lipoprotein lipase. I. Isolation and characterization of the enzyme from normal rat heart. J. biol. Chem. 215, 1 (1955). II.
Korn, E. D.: Substrate specificity and activation of coconut oil. J. biol. Chem. 215, 15 (1955).
Korn, E. D., and T. W. Quigley Jr.: Studies on lipoprotein lipase of rat heart and adipose tissue. Biochem. biophys. acta 18, 143 (1955).
Koszalka, M. F., and J. J. Levin: Idiopathic hyperlipemia. Ann. intern. Med. 33, 473 (1950).
Kunkel, H. G., and E. H. Ahrens Jr.: The relationship between serum lipids and the electrophoretic pattern, with particular reference to patients with primary biliary cirrhosis. J. clin. Invest. 28, 1575 (1949).
Leonhardi, G.: Fettstoffwechseluntersuchungen bei Xanthomatosen. Arch. klin. exp. Derm. 206, 582 (1957).
Lever, W. F.: Bestimmung der Lipoproteine und Glykoproteine im Plasma von Patienten mit verschiedenen Hautkrankheiten. Hautarzt 4, 426 (1953).
Lever, W. F.: Primäre hypercholesterinämische Xanthomatose und idiopathische Hyperlipämie. Fortschr. prakt. Derm. 2, 186 (1955).
Lever, W. F., u. B. Baskys: Effects of intravenous administration of fat emulsions and their emulsifying agents. I. Effects on clearing factor activity, electrophoretic pattern and clotting time of blood of dogs. J. invest. Derm. 28, 317 (1957).
Lever, W. F., F. R. N. Gtjrd, E. Uroma, R. K. Brown, B. A. Barnes, K. Schmid and E.L. Schultz: Chemical, clinical and immunological studies on the products of human plasma fractionation. XL. Quantitative separation and determination of the protein components in small amounts of normal human plasma. J. clin. Invest. 30, 99 (1951).
Lever, W. F., F. S. M. Herbst and N. A. Hurley: Idiopathic hyperlipemia and primary hyper-cholesteremic xanthomatosis. IV. Effect of prolonged administration of heparin on the serum lipids in idiopathic hyperlipemia. A.M.A. Arch. Derm. 71, 150 (1955).
Lever, W. F., F. S. M. Herbst and M. E. Lyons: Idiopathic hyperlipemia and primary hypercholesteremic xanthomatosis. V. Analysis of the serum lipoproteins by means of the ultracentrifuge before and after the administration of heparin. A.M.A. Arch. Derm. 71, 158 (1955).
Lever, W. F., and E. Klein: Untersuchungen Über die Pathogenese der idiopathischen Hyperlipämie. Dermatologica (Basel) 115, 579 (1957) (I).
Lever, W. F., and E. Klein: The inhibition of lipemia-clearing by hyper-lipemic serum. J. invest. Derm. 29, 465 (1957) (II).
Lever, W. F., and E. Klein: Hemmung des Klärungsfaktors und der Pankreaslipase durch das Serum von Patienten mit idiopathischer Hyperlipämie. Hautarzt 10, 352 (1959)..
Lever, W. F., and J. G. MacLean: Primary familial xanthomatosis and biliary xanthomatosis (biliary cirrhosis with xanthomatosis). J. invest. Derm. 15, 173 (1950).
Lever, W. F., P. A. J. Smith and N. A. Hurley: Idiopathic hyperlipemia and primary hypercholesteremic xanthomatosis. I. Clinical data and analysis of the plasma lipids. J. invest. Derm. 22, 33 (1954).
Lever, W. F., P. A. J. Smith and N. A. Hurley: II. Analysis of the plasma proteins and lipids by means of electrophoresis and fractionation of the plasma proteins; effect of high speed centrifugation and of extraction with ether on the plasma proteins and lipids. J. invest. Derm. 22, 53 (1954).
Lever, W. F., P. A. J. Smith and N. A. Hurley: III. Effects of intravenously administered heparin on the plasma proteins and lipids. J. invest. Derm. 22, 71 (1954).
Lever, W. F., and W. R. Waddell: Idiopathic hyperlipemia and primary hypercholesteremic xanthomatosis. VII. Effects of intravenously administered fat on the serum lipids. J. invest. Derm. 25, 233 (1955).
Levy, B. M.: Idiopathic lipemia. J. Pediat. 29, 367 (1946).
MacMahon, H. E., and S. J. Thannhauser: Xanthomatous biliary, cirrhosis (a clinical syndrome). Ann. intern. Med. 30, 41 (1949).
MacMahon, H. E., and S. J. Thannhauser: Biliary xanthomatosis (congenital acholangic biliary cirrhosis). Amer. J. Path. 27, 750 (1951).
Major, R. H.: Xanthoma diabeticorum. Bull. Johns Hopk. Hosp. 35, 27 (1925).
Malmros, H., B. Swahn and E. Truedsson: Essential hyperlipemia. Acta med. scand. 149, 91 (1954).
Malmros, H., and G. Wigand: Treatment of hypercholesteremia. Minn. Med. 38, 864 (1955).
Marcus, M.: The pancreas and intermediate fat metabolism. Folia clin, orient. (Tel-Aviv) 1, 127 (1937).
Martt, J. M., and W. E. Connor: Idiopathic hyperlipemia associated with coronary atherosclerosis. Arch. intern. Med. 97, 492 (1956).
Matras, A.: Hyperlipämische Xanthomatosen und ihre Behandlung mit Heparin. Arch. klin. exp. Derm. 203, 503 (1956).
McGinley, J., H. Jones and J. Gofman: Lipoproteins and xanthomatous diseases. J. invest. Derm. 19, 71 (1952).
Mellinghoff, K.: Primäre hyperlipoidämische Xanthomatose mit Diabetes. Z. klin. Med. 153, 185 (1955).
Montgomery, H., and A. E. Osterberg: Xanthomatosis: Correlation of clinical, histopathologic and chemical studies of cutaneous xanthoma. Arch. Derm. Syph. (Chicago) 37, 373 (1938).
Morris, B., and J. French: The uptake and metabolism of C14-labeled chylomicron fat by the isolated perfused liver of the rat. Quart. J. exp. Physiol. 43, 180 (1958).
Movitt, E. K., B. Gerstl, F. Sherwood and C. C. Epstein: Essential hyperlipemia. Arch. intern. Med. 87, 79 (1951).
Parsons, W. B., R. W. P. Achor, K. G. Berge, B. F. McKenzie and as: Changes in concentration of blood lipids following prolonged administration of large doses of nicotinic acid to persons with hypercholesterolemia: Preliminary observations. Proc. Mayo Clin 31, 377 (1956).
Peters, J. P., and E. B. Man: The interrelations of serum lipids in normal persons. J. clin. Invest. 22, 707 (1943).
Pfeiffer,E. F., u. H. Wirtz: Hyper-cholesterämische Xanthomatose bei intrahepatischem Verschlußikterus nach Salvarsan. Arch. Derm. Syph. (Berl.) 193, 99 (1951).
Pfleger, L., u. H. Tirschek: Xanthomatose bei idiopathischer Hyperlipämie und Pankreatitis. Wien. klin. Wschr. 68, 435 (1956).
Piper, J., u. L. Orrild: Essential familial hypercholesterolemia and xanthomatosis. Amer. J. Med. 21, 34 (1956).
Potjlsen, H. M.: Familial lipaemia. A new form of lipoidosis showing increase in neutral fats combined with attacks of acute pancreatitis. Acta med. scand. 138, 413 (1950).
Pürschel, W., u. S. Bust: Xanthomatose Haut- und Organveränderungen bei Hyperchol-esterinämie. Z. Haut- u. Geschl.-Kr. 15, 89 (1953).
Rigdon, R. H., and G. Willeford: Sudden death during childhood with xanthoma tuberosum. J. Amer. med. Ass. 142, 1268 (1950).
Riley, F. P., and A. Steiner: Effect of sitosterol on the concentration of serum lipids in patients with coronary atherosclerosis. Circulation 16, 723 (1957).
Robinson, D. S., D. M. Harris, J. C. F. Poole and G. H. Jeffries: The effect of a fat meal on the concentration of free fatty acids in human plasma. Biochem. J. 60, 37 (1955).
Ruiter, M., and L. Meyler: Skin changes after therapeutic administration of nicotinic acid in large doses. Dermatologica (Basel) 120, 139 (1960).
Ruskin, A.: The hypocholesterolemic effect of triparanol (MER-29) in man. Arch. intern. Med. 106, 803 (1960).
Russ, E. M., H. A. Eder and D. P. Barr: Influence of gonadal hormones on protein-lipid relationships in human plasma. Amer. J. Med. 19, 4 (1955).
Russ, E. M., J. Raymunt and D. P. Barr: Lipoproteins in primary biliary cirrhosis. J. clin. Invest. 35, 133 (1956).
Savitt, L. E.: Injection of hydrocortisone into dermatologic lesions. A.M.A. Arch. Derm. 76, 780 (1957).
Schade, H., and P. Saltman: Influence of nicotinic acid on hepatic cholesterol synthesis in rabbits. Proc. Soc. Exp. Biol. (N.Y.) 102, 265 (1959).
Schettler, G., M. Eggstein u. H. Jobst: Die essentielle Hyperlipämie. Dtsch. med. Wschr. 83, 1 (1958).
Schirren, C.: Hyperlipidämische Xanthomatosen. Hautarzt 8, 119 (1957).
Schoenheimer, R., and W. M. Sperry: A micromethod for the determination of free and combined cholesterol. J. biol. Chem. 106, 745 (1934).
Schrade, W., G. Becker u. E. Bohle: Das Krankheitsbild der idiopathischen Hyperlipämie. Deutsch. Arch. f. klin. Med. 201, 344 (1954).
Shay, H., and C. Harris: Changing concepts of ”xanthomatous biliary cirrhosis”. Amer. J. med. Sci. 223, 286 (1952).
Spellberg, M. A., and F. A. Gattas: Xanthomatous biliary cirrhosis in the male. Gastroenterology 28, 55 (1957).
Steiner, A., A. Varson and D. Rudman: Effect of a formula diet containing various vegetable oils upon the serum lipids of human subjects. Circulation 16, 495 (1957).
Stolzer, B. L., G. Miller, W.A. White and M. Zuckerbrod: Postarsenical obstructive jaundice complicated by xanthomatosis and diabetes mellitus. Amer. J. Med. 9, 124 (1950).
Swahn, B.: A method for localization and determination of serum lipids after electrophoreti-calseparation on filter paper. Scand. J. clin. Lab. Invest. 4, 98 (1952).
Sweitzer, S.E., and L. H. Winer: Xanthoma tuberosum and myxedema. Arch. Derm. Syph. (Chicago) 42, 419 (1940).
Taylor, W. B., and A. C. Curtis: Hyperlipemic xanthomatosis in a patient with subacute glomerulonephritis (nephrotic stage). Arch. Derm. Syph. (Chicago) 70, 518 (1954).
Thannhauser, S. J.: Lipidoses, 3. Aufl. New York: Grune u. Strutton 1958.
Thannhauser, S. J., and H. Magendantz: The different clinical groups of xanthomatous diseases; a clinical physiological study of 22 cases. Ann. intern. Med. 11, 1662 (1938).
Thannhauser, S. J., and M. M. Stanley: Serum fat curve following oral administration of I131-labelled neutral fat to normal subjects and those with idiopathic hyperlipemia. Trans. Ass. Amer. Physicians 62, 245 (1949).
Tomkins, G. M., H. Sheppard and I. L. Chaikofe: Cholesterol synthesis by liver. III. Its regulation by ingested cholesterol. J. biol. Chem. 201, 137 (1953).
Urbach, E.: Lipoidstoffwechselerkrankungen der Haut. In Handbuch der Haut- und Geschlechtskrankheiten, herausgeg. von J. Jadassohn, Bd. XII/2, S. 238. Berlin: Springer 1932.
Weidman, F.D., and L.N. Boston: Generalized xanthoma tuberosum with xanthomatous changes in fresh scars of intercurrent zoster; adenocarinoma of ampulla of Vater at necropsy. Arch. intern. Med. 59, 793 (1937).
Wheeler, E. O., and H. B. Sprague: The prevalence and significance of hypercholesterolemia among children and siblings of patients with hypercholesterolemic xanthomatosis. J. clin. Invest. 32, 611 (1953).
Wijnhatjsen, O. J.: Über Xanthomatose in einem Falle von recidivierender Pankreatitis. Berl. klin. Wschr. 58, 1268 (1921).
Wilkinson Jr., C. F., E. Boyle, R. S. Jackson and M. R. Benjamin: The effect of varying the intake of dietary fat and the ingestion of sitosterol on the lipid fractions of human serum. Metabolism 4, 302 (1955).
Wilkinson, C. F., E. A. Hand and M. T. Fliegelman: Essential familial hypercholesterolemia. Ann. intern. Med. 29, 671 (1948).
Wise, F., and J. Garb: Xanthoma diabeticorum with unusual form of eruption. Arch. Derm. Syph. (Chicago) 45, 723 (1942).
Zakon, S. J., A. Oyamada and I.H. Rosenthal: Eruptive xanthoma and hyperlipemia in glycogen storage disease (von Gierke’s disease). A.M.A. Arch. Derm. Syph. 67, 146 (1935).
B, II, 1. Histiocytose (S. 115)
Abt, A. F., and E. J. Denenholz: Letterer-Siwe’s disease: Splenomegaly associated with widespread hyperplasia of non-lipid-storing macrophages; discussion of the so-called reticulo-endothelioses. Amer. J. Dis. Child. 51, 499 (1936).
Ausset, E.: Un cas de diabète insipide chez un enfant de quatre ans. Eruption xanthélasmique généralisée concomitante. Bull. Soc. méd. Hôp. Paris 16, 150 (1899).
Bass, M. H., S. O. Sapin and H. L. Hodes: Use of cortisone and corticotropin (ACTH) in treatment of reticuloendotheliosis in children. A.M.A. J. Dis. Child. 85, 393 (1953).
Batson, R., J. Shapiro, A. Christie and H. D. Riley Jr.: Acute nonlipid disseminated reticuloendotheliosis. Amer. J. Dis. Child. 90, 323 (1955).
Bierman, H. R., J. T. Lanman, K. S. Dod, K.H. Kelly, E.R. Miller and M. B. Shimkin: The ameliorative effect of antibiotics on nonlipid reticuloendotheliosis (Letterer-Siwe disease) in identical twins. J. Pediat. 40, 269 (1952).
Blahd, W. H., M. S. Levy and S. H. Bassett: A case of Hand-Schüller-Christian syndrome treated with cortisone. Ann. intern. Med. 35, 927 (1951).
Brattn-Falco, O., u. F. Braun-Falco: Zum Syndrom „Diabetes insipidus und disseminierte Xanthome“. Z. Laryng. Rhinol. 36, 378 (1957).
Burgstedt: Frühkindliche Reticulo-endotheliose. Hautarzt 5, 557 (1954).
Ceelen, W.: Über die Lipoidgranulomatose (Hand-Schüller-Christansche Krankheit). Dtsch. med. Wschr. 59, 680 (1933).
Chamberlain, W. E.: In der Diskussion zu D. S. Childs Jr. u. L. J. Kennedy.
Chester, W.: Über Lipoidgranulomatose. Virchows Arch. path. Anat. 279, 561 (1930).
Childs, D. S., and L.J. Kennedy: Reticulo-endotheliosis of children: Treatment with Roentgen rays. Radiology 57, 653 (1951).
Christian, H. A.: Defects in membranous bones, exophthalmos and diabetes insipidus. Med. Clin. N. Amer. 3, 849 (1920).
Crocker, A. C.: Skin xanthomas in childhood. Pediatrics 8, 573 (1951).
Ctjrrens, J. H., and W. C. Popp: XanthomatosisHand-Schüller-Christian type: Report of a case with pulmonary fibrosis. Amer. J. Med. Sci. 205, 780 (1943).
Curtis, A. C., and E. P. Cawley: Eosinophilic granuloma of bone with cutaneous manifestations. Arch. Derm. Syph. (Chicago) 55, 810 (1947).
Dennis, J. W., and P. D. Rosahn: The primary reticuloendothelial granulomas. Amer. J. Path. 27, 627 (1951).
Engelbreth-Holm, J., G. Teilum and E. Christensen: Eosinophil granuloma of bone; Schüller-Christian’s disease. Acta med. scand. 118, 292 (1944).
Epstein, E.: Die generalisierten Affektionen des histiozytären Zellensystems (Histiozytomatosen). Med. Klin. 21, 1501, 1542 (1925).
Erber, L.J.: Über sogenannte Retikulose mit Fettspeicherung. Virchows Arch. path. Anat. 282, 621 (1931).
Farber, L.: The nature of ”solitary or eosinophilic granuloma” of bone. Amer. J. Path. 17, 625 (1941).
Farber, L.: The nature of some diseases ascribed to disorders of lipid metabolism. Amer. J. Dis. Child. 68, 350 (1944).
Finzi, O.: Mieloma con prevalenza della cellule eosinofile, circoscritto all’osso frontale in un giovane die 15 anni. Minerva med. (Torino) 9, 239 (1929).
Flori, G. A., and G. C. Parenti: Reticuloendoteliosi iperplastica infettiva adevoluzione granulo-xantomatose (tipo Hand-Schüller-Christian). Riv. Clin, pediat. 35, 193 (1937).
Flosi, A. Z., L. M. Assis, W. Bloise, A. S. Coelho Netto, A. B. Ulhoa Cintra and R. P. de Barros: Treatment of eosinophilic granuloma by corticotropin: report of 4 cases with disappearance of the bone lesions. J. Clin. Endocrin. 17, 994 (1957).
Foot, N. C., and C. T. Olcott: Report of a case of nonlipid histiocytosis (reticuloendotheliosis) with autopsy. Amer. J. Path. 10, 81 (1934).
Freund, M., and M. L. Ripps: Hand-Schüller-Christian disease; case in which lymphadenopathy was predominant feature. Amer. J. Dis. Child. 61, 759 (1941).
Gerstel, G.: Über die Hand-Schüller-Christiansche Krankheit auf Grund gänzlicher Durchuntersuchung des Knochengerüstes. Virchows Arch. path. Anat. 294, 278 (1934).
Gigon, A.: Zur Kenntnis der Schüller-Christianschen Krankheit. Schweiz, med. Wschr. 62, 4 (1932).
Glanzmann, E.: Infektiöse Retikuloendotheliose (Abt-Letterer-Siwesche Krankheit) und ihre Beziehungen zum Morbus Schüller-Christian. Ann. paediat. (Basel) 155, 1 (1940).
Gottron, H. A.: In der Aussprache zu H. E. Anders, Die Schüller-Christiansche Krankheit. Derm. Z. 62, 287 (1931).
Gottron, H. A.: Schüller-Christiansche Krankheit unter besonderer Berücksichtigung der Hautveränderungen. Arch. Derm. Syph. (Berl.) 182, 691 (1942).
Gross, P., and H. W. Jacox: Eosinophilic granuloma of bone and certain other reticuloendothelial hyperplasias of bone. Amer. J. med. Sci. 203, 673 (1942).
Hand Jr., A.: Polyuria and tuberculosis. Arch. Pediat. 10, 673 (1893).
Heller, J. H.: Effect of cortisone on the function, capacity and activity of the reticuloendothelial system. Fed. Proc. 12, 65 (1953).
Henschen, F.: Über Christians Syndrom und dessen Beziehungen zur allgemeinen Xanthomatose. Acta paediat. (Uppsala) 12, Suppl. 6, 1 (1931).
Herrmann, F., u. E. Nathan: Zur Frage der Xanthomgenese. Arch. Derm. Syph. (Berl.) 152, 575 (1926).
Herzau, W., u. H. Pinkus: Beitrag zur Schüller-Christianschen Krankheit. Klin. Mbl. Augenheilk. 89, 721 (1932).
Hodgson, J. R., R. L. J. Kennedy and J. D. Camp: Reticulo-endotheliosis. Radiology 57, 642 (1951).
Jaffe, H. L., and L. Lichtenstein: Eosinophilie granuloma of bone. Arch. Path. (Chicago) 37, 99 (1944).
Jausion, H., A. Roussel et A. Bellalouna: Curieuse évolution d’une Xanthomatose éruptive, avec diabète insipide. Bull. Soc. franç. Derm. Syph. 61, 469 (1954).
Kay, T. W.: Acquired hydrocephalus with atrophie bone changes, exophthalmos and polyuria. Penn. med. J. 9, 520 (1905).
Keizer, D. P. R., and R. R. Rochat: Malignant reticuloendotheliosis (Letterer-Siwe disease). Amer. J. Dis. Child. 87, 328 (1954).
Kierland, R. B., J. G. Epstein and W. E. Weber: Eosinophilic granuloma of skin and mucous membranes. A.M.A. Arch. Derm. 75, 45 (1957).
Lane, C. W., and M. G. Smith: Cutaneous manifestations of chronic (idiopathic) lipoidosis (Hand-Schüller-Christian disease). Arch. Derm. Syph. (Chicago) 39, 617 (1939).
Langer, I., u. G. Leonhardi: Beitrag zur Therapie und Pathogenese der Abt-Letterer-Siwe-Erkrankung. Arch. klin. exp. Derm. 207, 141 (1958).
Lausecker, H.: Abt-Letterer-Siwesche Krankheit bei Zwillingen. Wien. klin. Wschr. 68, 433 (1956).
Laymon, C. W., and J. J. Sevenants: Systemic reticuloendothelial granuloma. Arch. Derm. Syph. (Chicago) 57, 873 (1948).
Letterer, E.: Aleukämische Retikulose. Ein Beitrag zu den proliferativen Erkrankungen des Retikuloendothelialapparates. Frankfurt. Z. Path. 30, 377 (1924).
Letterer, E.: Lipoid-chemische Untersuchung einer xanthösen Lymphogranulomatose in ihrer Beziehung zur Handschen Krankheit. Klin. Wschr. 13, 1046 (1934).
Lever, W. F.: Xanthomas. In: Current Therapy, herausgeg. von H. F. Conn, S. 505. Philadelphia: W. B. Saunders Company 1960.
Lever, W. F., and R. W. Leeper: Eosinophilie granuloma of the skin. Report of cases representing the two different diseases described as eosinophilic granuloma of the skin. Arch. Derm. Syph. (Chicago) 62, 85 (1950).
Levin, H.: The use of cortisone in the treatment of reticuloendotheliosis. J. Pediat. 46, 531 (1955).
Lewis, G. M.: Eosinophilic granuloma of pituitary gland, lungs, bones of the skull and skin. Arch. Derm. Syph. (Chicago) 60, 1007 (1949).
Lichtenstein, L.: Histiocytosis X. Arch. Path. (Chicago) 56, 84 (1953).
Lichtenstein, L., and H. L. Jaffe: Eosinophilic granuloma of bone, with report of a case. Amer. J. Path. 16, 595 (1940).
Lipton, E. L.: Hemolytic and pancytopenic syndrome associated with Letterer-Siwe disease. Pediatrics 14, 533 (1954).
MacKelvie, A. A., and W.W. Park: Letterer-Siwe’s disease. Arch. Dis. Child. 25, 955 (1942).
Mallory, T. B.: Pathology: Diseases of bone. New Engl. J. Med. 227, 955 (1942).
Mazzitello, W. F.: Eosinophilic granuloma of the lung. New Engl. J. Med. 250, 804 (1954).
McCreary, J. H.: Eosinophilic granuloma, with simultaneous involvement of skin and bones. Arch. Derm. Syph. (Chicago) 58, 372 (1948).
McCullough, N. B.: Eosinophilic granuloma with multiple osseous and soft tissue lesions in an adult. Arch. intern. Med. 88, 243 (1951).
McKay, D. G., R. B. Street, K. Benirschke and C. J. Duncan: Eosinophilic granuloma of the vulva. Surg. Gynec. Obstet. 96, 437 (1953).
Mermann, A.C., and H. W. Dargeon: The management of certain nonlipid reticulo-endothelioses. Cancer (Philad.) 8, 112 (1955).
Merritt, K. K., and B. H. Paige: Xanthomatosis (Schüller-Christian syndrome). Amer. J. Dis. Child. 46, 1368 (1933).
Meyer, E.: Hand-Schüller-Christian disease or eosinophilic xanthomatous granuloma. Amer. J. Med. 15, 130 (1953).
Montgomery, H., and A. E. Österberg: Xanthomatosis. Arch. Derm. Syph. (Chicago) 37, 373 (1938).
Oswald, N., and T. Parkinson: Honeycomb lungs. Quart. J. Med. 18, 1 (1949).
Otani, S., and J. C. Ehrlich: Solitary granuloma of bone simulating primary neoplasm. Amer. J. Path. 16, 479 (1940).
Pinkus, H., L. A. Copps, S. Custer and S. Epstein: Reticulogranuloma. Amer. J. Dis. Child. 77, 503 (1949).
Polano, M. K.: Über die Pathogenese der Cholesterosen der Haut. Arch. Derm. Syph. (Berl.) 174, 213 (1936).
Prouty, M.: Remission of Letterer-Siwe disease after prednisone therapy. J. Amer. med. Ass. 169, 1877 (1959).
Pusey, W. A., and O. P. Johnstone: A case of xanthoma diabeticorum and lipoma multiplex and a case of xanthoma approaching the diabetic type with diabetes insipidus. J. cutan. Dis. 26, 552 (1908).
Rowland, R. S.: Christian’s syndrome and lipoid cell hyperplasias of the reticuloendothelial system. Ann. intern. Med. 2, 1277 (1928/29).
Ruch, D. M.: Cutaneous manifestations of Letterer-Siwe’s disease. A.M.A. Arch. Derm. 75, 88 (1957).
Schäfer, E. L.: Nonlipid reticulo-endotheliosis: Letterer-Siwe’s disease. Amer. J. Path. 25, 49 (1949).
Schüller, A.: Über eigenartige Schädeldefekte im Jugendalter. Fortschr. Röntgenstr. 23, 12 (1915/16).
Schuknecht, H. F., and H. B. Perlman: Hand-Schüller-Christian disease and eosinophilic granuloma of the skull. Ann. Otol. (St. Louis) 57, 643 (1948).
Schultz, A., F. Wermbter u. H. Puhl: Eigentümliche granulomartige Systemerkrankung des hämatopoetischen Apparates (Hyperplasie des retikuloendothelialen Apparates). Virchows Arch. path. Anat. 252, 519 (1924).
Siemens, H. W.: Zur Kenntnis der Xanthome. Arch. Derm. Syph. (Berl.) 136, 159 (1921).
Siwe, S.A.: Die Reticulo-endotheliose ein neues Krankheitsbild unter den Hepatosplenomegalien.Kinderheilk. 55, 212 (1933). —
Siwe, S.A.:The reticulo-endothelioses in children. Advanc. Pediat. 4, 117 (1949).
Smith, T.: Skull-cap showing congenital deficiencies of bone. Trans, path. Soc. Lond. 16, 224 (1864/65).
Sosman, M. C.: Xanthomatosis (Schüller-Christian’s disease; lipoid histiocytosis). J. Amer. med. Ass. 98, 110 (1932).
Steele, H. D.: Letterer-Siwe’s disease: report of a case. Arch. Pediat. 67, 205 (1950).
Stepantschitz, G., u. B. Schreiner: Beitrag zur Klinik und Therapie der Hand-Schüller-Christianschen Erkrankung. Wien. med. Wschr. 65, 301 (1953).
Stoughton, R. B., and B. Stone: Lipoid storage disease (Eosinophilic granuloma ? Hand-Schüller-Christiandisease ?) A.M.A. Arch.Derm. 72, 78 (1955).
Sweitzer, S. E., and C. W. Laymon: Letterer-Siwe disease. Arch. Derm. Syph. (Chicago) 59, 549 (1949).
Sweitzer, S. E., L. H. Winer and H.A. Cumming: Reticuloendotheliosis. Arch. Derm. Syph. (Chicago) 40, 192 (1939).
Tate, B.C.: Cutaneous xanthomata associated with intermittent diabetes insipidus; high blood-fat and normal cholesterol. Proc. roy. Soc. Med. 26, 1546 (1933).
Thannhauser, S. J.: Lipidoses, 3. Aufl. New York: Grune u. Stratton 1958.
Thannhauser, S. J., and H. Magendantz: The different clinical groups of xanthomatous diseases; a clinical physiological study of 22 cases. Ann. intern. Med. 11, 1662 (1938).
Urbach, E.: Lipoidstof f Wechselerkrankungen der Haut. In: Jadassohn, J.: Handbuch der Haut- und Geschlechtskrankheiten, Bd. 12, Teil 2, S. 238. Berlin: Springer 1932.
Wallgren, A.: Systemic reticuloendothelial granuloma. Amer. J. Dis. Child. 60, 471 (1940).
Weinstein, A., H.C. Françis and B. F. Sprofkin: Eosinophilic granuloma of bone. Report of a case with multiple lesions of bone and pulmonary infiltration. Arch. intern. Med. 79, 176 (1947).
B, II, 2. Angiokeratoma corporis diffusum (S. 133)
Anderson, W.: A case of ”angiokeratoma”. Brit. J. Derm. 10, 113 (1898).
Bechet, P.: Multiple disseminated angioma. Arch. Derm. Syph. (Chicago) 46, 165 (1942).
Brown, A., and J.A. Milne: Diffuse angiokeratoma: report of two cases with diffuse skin changes, one with neurological symptoms and splenomegaly. Glasg. med. J. 33, 361 (1952).
Duperrat, B.: L’angiokératome diffus de Fabry (angiokeratoma corporis diffusum). Presse med. 67, 1814 (1959).
Fabry, J.: Ein Beitrag zur Kenntnis der Purpura haemorrhagica nodularis (Purpura papulosa haemorrhagica Hebrae). Arch. Derm. Syph. (Berl.) 43, 187 (1898).
Falck, L.: Angiokeratoma corporis diffusum Fabry mit vaso-renalem Symptomenkomplex. Samml. selt. klin. Fälle 9, 20 (1955).
Falck, L., u. A. Weicksel: Samml. selt. klin. Fälle 13, 20 (1957).
Fessas, P., M. M. Wintrobe and G. E. Cartwright: Angiokeratoma corporis diffusum universale (Fabry). Arch. intern. Med. 95, 469 (1955).
Fuhs, H.: Naevus angio-keratosus. Derm. Wschr. 89, 1815 (1929).
Groot, W.P. de: Thesaurismosis Ruiter-Pompen-Wyers-Kühnau. Dermatologica (Basel) 114, 46 (1957).
Hornbostel, H., u. K. Scriba: Zur Diagnostik des Angiokeratoma Fabry mit kardio-vasorenalem Symptomenkomplex als Phosphatidspeicherungskrankheit durch Probeexcision der Haut. Klin. Wschr. 31, 68 (1953).
Hornbostel, H., W. Spier u. H. Koch: Angiokeratoma corporis diffusum universale (Fabry) mit kardio-vaso-renalem Symptomenkomplex als Allgemeinerkrankung. Ärztl. Wschr. 6, 49 (1951).
Hornbostel, H., W. Spier, H. Koch u. K. Scriba: Angiokeratoma corporis diffusum Fabry mit cardio-vaso-renalem Symptomenkomplex als Allgemeinerkrankung auf dem Boden einer Thesaurismose. Hautarzt 1, 183 (1950).
Lapière, S.: Angiokeratoma corporis diffusum (Fabry). Dermatologica (Basel) 115, 572 (1957).
Madden, J. F.: Generalized angiomatosis (telangiectasia). J. Amer. med. Ass. 102, 442 (1934).
Pittelkow, R. B., R. R. Kierland and H. Montgomery: Angiokeratoma corporis diffusum. A.M.A. Arch. Derm. 72, 556 (1955).
Pittelkow, R. B., R. R. Kierland and H. Montgomery: Polariscopic and histochemical studies in angiokeratoma corporis diffusum. A.M.A. Arch. Derm. 76, 59 (1957).
Pompen, A. W. M., M. Rtjiter and H. J. G. Wijers: Angiokeratoma corporis diffusum (universale) Fabry, as a sign of an unknown internal disease; two autopsy reports. Acta med. scand. 128, 234 (1947).
Price, J. H.: Angiokeratoma corporis diffusum. Brit. J. Derm. 67, 105 (1955).
Rtjiter, M.: Angiokeratoma corporis diffusum. A.M.A. Arch. Derm. Syph. 68, 21 (1953).
Rtjiter, M.: Histological investigation of the skin in angiokeratoma corporis diffusum in particular with regard to the associated disturbance of phosphatid metabolism. Dermatologica (Basel) 109, 273 (1954).
Rtjiter, M.: Some further observations on angiokeratoma corporis diffusum. Brit. J. Derm. 69, 137 (1957).
Rtjiter, M.: Das Angiokeratoma corporis diffusum-Syndrom und seine Haut-erscheinungen. Hautarzt 9, 15 (1958).
Rtjiter, M., u. A. W. M. Pompek: Angiokeratoma corporis diffusum (universale) mit kardiovasorenalem Symptomenkomplex bei 3 Brüdern. Arch. Derm. Syph. (Berl.) 179, 165 (1939).
Rtjiter, M., A. W. M. Pompek u. H. J. G. Wijers: Über interne und pathologisch-anatomische Befunde bei Angiokeratoma corporis diffusum (Fabry). Dermatologica (Basel) 94, 1 (1947).
Scriba, K.: Zur Pathogenese des Angiokeratoma corporis diffusum Fabry mit cardio-vasorenalem Symptomenkomplex. Verh. dtsch. Ges. Path. 34, 221 (1950).
Sibley, W. K.: Case for diagnosis. Brit. J. Derm. 30, 109 (1918).
Siguier, F., B. Dtjperrat, u. Bétotjrné et A. Hanaut: Angiokératose de Fabry, expression cutanée d’une maladie générale, nouvellement individualisée. Bull. Soc. méd. Hôp. Paris 72, 291 (1956).
Steiner, L., u. H. Vorner: Angiomatosis miliaris, eine idiopathische Gefäßerkrankung. Dtsch. Arch. klin. Med. 96, 105 (1909).
Stümpke, G.: Ein Fall von Angiokeratoma corporis diffusum. Arch. Derm. Syph. (Berl.) 121, 291 (1916).
Volavesek: Angiokeratoma corporis diffusum (Fabry). Derm. Wschr. 111, 800 (1940).
Wallace, H. J.: Angiokeratoma corporis diffusum. Brit. J. Derm. 70, 354 (1958).
Weicksel, J.: Angiomatosis bzw. Angiokeratoma universalis (eine sehr seltene Haut- und Gefäßerkrankung). Dtsch. med. Wschr. 51, 898 (1925).
Wertheim, L.: Hämangiome. In Handbuch der Haut- und Geschlechtskrankheiten, herausgeg. von J. Jadassohn. Bd. XII/2, S. 423. Berlin: Springer 1932.
Wohnlich, H.: Zur Symptomatologie multipler Angiome. Arch. Derm. Syph. (Berl.) 187, 528 (1949).
Yu, K. Y.: Angiokeratoma corporis diffusum universale (Fabry). Chin. med. J. 74, 478 (1956).
B, II, 3. Gauchersche Krankheit(S. 141)
East, T., and L. H. Savin: A case of Gaucher’s disease with biopsy of the typical Pingueculae. Brit. J. Ophthal. 24, 611 (1940).
Kveim, A.: Drei Fälle von Morbus Gaucher. Acta derm.-venereol. (Stockh.) 17, 500 (1936).
Reich, C., M. Seife and B. J. Kessler: Gaucher’s disease: a review, and discussion of twenty cases. Medicine (Baltimore) 30, 1 (1951).
Thannhatjser, S. J.: Lipidoses, 3. Aufl., S. 455. New York: Grune u. Stratton 1958.
B, II, 4. Niemann-Picksche Krankheit (S. 141)
Crocker, A. C., and S. Farber: Niemann-Pick disease: a review of eighteen patients. Medicine (Baltimore) 37, 1 (1958).
Merksamer, D., and B. Kramer: Niemann-Pick’s disease. J. Pediat. 14, 51 (1939).
Schaferstein, S. J.: Die Pick-Niemann’sche Krankheit. Acta paediat. (Uppsala) 10, 523 (1930/31).
Thannhauser, S. J.: Lipidoses, 3. Aufl., S. 524. New York: Grune u. Stratton 1958.
Videbaek, A.: Memann-Pick’s disease. Acta paediat. (Uppsala) 37, 95 (1949).
B, III 1. Nekrobiosis lipoidica (S. 142)
Balbi, E.: Ricerche intorno alla patogenesi della necrobiosis lipoidica diabeticorum Urbach-Oppenheim. G. ital. Derm. Sif. 74, 14 (1933).
Belote, G. H., and D. G. Welton: Necrobiosis without diabetes. Arch. Derm. Syph. (Chicago) 40, 887 (1939).
Bernstein, J. C.: Necrobiosis lipoidica diabeticorum (Urbach). Arch. Derm. Syph. (Chicago) 36, 282 (1937).
Boldt, A.: Zur Kenntnis der Necrobiosis lipoidica („diabeticorum“). Arch. Derm. Syph. (Berl.) 179, 74 (1939).
Bonse, G.: Weichstrahl-Röntgenbefunde bei Necrobiosis lipoidica (”diabeticorum”). Arch. Derm. Syph. (Berl.) 192, 509 (1951).
Bruce-Jones, D. B. S.: A case clinically resembling morphea with a tuberculous background and indeterminate histology suggestive of necrobiosis lipoidica. Brit. J. Derm. 49, 238 (1937).
Cawley, E. P., and R. O. Dingman: Necrobiosis lipoidica diabeticorum: Its surgical treatment. A.M.A. Arch. Derm. Syph. 63, 764 (1951).
Ellis, F. A.: Necrobiosis lipoidica. A form of granuloma annulare ? Arch. Derm. Syph. (Chicago) 43, 822 (1941). —
Ellis, F. A.: In der Diskussion zu C. W. Laymon u. I. Fisher: Arch. Derm. Syph. (Chicago) 59, 150 (1949).
Ellis, F. A., and H. Kirby-Smith: Necrobiosis lipoidica and granuloma annulare. Arch. Derm. Syph. (Chicago) 45, 40 (1942).
Feldman, F. F.: In der Diskussion zu H. Price, Necrobiosis lipoidica diabeticorum. Arch. Derm. Syph. (Chicago) 67, 638 (1953).
Gertler, W.: Die nosologische Stellung der Granulomatosis (tuberculoides) pseudo-sklerodermiformis symmetrica chronica (Gottron) (Granulomatosis disciformis chronica et progressiva [Miescher]). Derm. Wschr. 141, 241 (1960).
Götz, H.: Zur Frage der Beziehungen zwischen der Granulomatosis disciformis chronica et progressiva (Miescher) und der Necrobiosis lipoidica diabeticorum. Hautarzt 7,156 (1956).
Goldsmith, W. N.: Necrobiosis lipoidica. Proc. roy. Soc. Med. 28, 363 (1935).
Goldsmith, W. N.: Granulomatosis disciformis chronica et progressiva (Miescher). Proc. of the Xth Internat. Congr. of Derm., Brit. med. Ass., London 1953.
Gottron, H. A.: Granulomatosis (tuberculoides) pseudosclerodermiformis symmetrica chronica. Arch. Derm. Syph. (Berl.) 172, 142 (1935).
Gottron, H. A.: Zur Kenntnis und Pathogenese der Dermatitis atrophicans lipoides diabetica bzw. Nekrobiosis lipoidica diabetica. Med. Klin. 34, 145, 190 (1938).
Greenwood, A. M., and E. N. Rockwood: Necrobiosis lipoidica diabeticorum. Arch. Derm. Syph. (Chicago) 35,727 (1937).
Gross, P., and G. F. Machacek: Necrobiosis lipoidica diabeticorum. Arch. Derm. Syph. (Chicago) 32, 491 (1935).
Hare, P. J.: Necrobiosis lipoidica. Brit. J. Derm. 67, 365 (1955).
Hare, P. J.: Necrobiosis lipoidica diabeticorum improving under treatment with local hydrocortisone injections. Brit. J. Derm. 69, 105 (1957).
Heite, H.-J., u. H. X. Scharwenka: Erythema elevatum diutinum, Granuloma anulare, Necrobiosis lipoidica und Granulomatosis disciformis Gottron-Miescher. Eine vergleichende häufigkeitsanalytische Studie. Arch. klin. exp. Derm. 208, 260 (1959).
Hildebrand, A. G., H. Montgomery u. E. H. Rynearson: Necrobiosis lipoidica diabeticorum. Arch. intern. Med. 66, 851 (1940).
Hitch, J. M.: Necrobiosis lipoidica diabeticorum (Urbach and Oppenheim). Arch. Derm. Syph. (Chicago) 36, 536 (1937).
Kaalund-Jorgensen, O.: Necrobiosis lipoidica (diabeticorum). Acta derm.-venereol. (Stockh.) 28, 214 (1948).
Klaber, R.: Necrobiosis lipoidica diabeticorum: Report of a case. Brit. J. Derm. 46, 226 (1934).
Knoth, W., u. H. Füller: Zur Patho- und Histogenese der Nekrobiosis lipoidica ”diabeticorum”. Arch. Derm. Syph. (Berl.) 199, 109 (1955).
Laymon, C. W., and I. Fisher: Necrobiosis lipoidica (diabeticorum?). A histologic study and comparison with granuloma annulare. Arch. Derm. Syph. (Chicago) 59, 150 1949).
Leifer, W.: Necrobiosis lipoidica diabeticorum in a nondiabetic person. Arch. Derm. Syph. (Chicago) 44, 717 (1941).
Lever, W. F.: In der Diskussion zu M. E. Helman, Necrobiosis lipoidica diabeticorum. Arch. Derm. Syph. (Chicago) 69, 386 (1954).
Marten, R. H., u. M. Dulake: Hydrocortisone in necrobiosis lipoidica diabeticorum. Brit. J. Derm. 69, 395 (1957).
Michelson, H. E., and C. W. Laymon: Necrobiosis lipoidica diabeticorum (Urbach). J. Amer. med. Ass. 103, 163 (1934).
Michelson, H. E., and C. W. Laymon: Necrobiosis lipoidica diabeticorum. Arch. Derm. Syph. (Chicago) 35, 1130 (1937).
Miescher, G.: Nekrobiosis maculosa. Dermatologica (Basel) 98, 199 (1949).
Miescher, G., u. M. Leder: Granulomatosis disciformis chronica et progressiva. Dermatologica (Basel) 97, 25 (1948).
Nicholas, L.: Necrobiosis lipoidica diabeticorum with xanthoma cells. Arch. Derm. Syph. (Chicago) 48, 606 (1943).
Nomland, R.: In der Diskussion zu: Omens, D., H. Omens, u. D. Musgrave: Granuloma annulare. Arch. Derm. Syph. (Chicago) 64, 94 (1951).
O’Leary, P. A.: In der Diskussion zu H. E. Michelson, Necrobiosis lipoidica diabeticorum. Arch. Derm. Syph. (Chicago) 30, 898 (1934).
Oppenheim, M.: Eigentümliche disseminierte Degeneration des Bindegewebes der Haut bei einem Diabetiker. Zbl. Haut- u. Geschl.-Kr. 32, 179 (1929).
Oppenheim, M.: Über eine bisher nicht beschriebene, mit eigentümlicher lipoider Degeneration der Elastica und des Bindegewebes einhergehende chronische Dermatose bei Diabetes mellitus. Arch. Derm. Syph. (Berl.) 166, 576 (1932).
Pascher, F., and S. C. Clyman: Necrobiosis lipoidica. A.M.A. Arch. Derm. Syph. 70, 823 (1954).
Price, H.: Necrobiosis lipoidica diabeticorum. Arch. Derm. Syph. (Chicago) 67, 638 (1953).
Prunty, F. C., and H. Montgomery: Granuloma annulare. Arch. Derm. Syph. (Chicago) 46, 394 (1942).
Roederer, J., F. Woringer et R. Burgun: Considérations sur un cas de nécrobiose lipoidique. Dermatologica (Basel) 99, 131 (1949).
Rollins, T. G., and R. K. Winkelmann; Necrobiosis lipoidica granulomatosa, A. M. A. Arch. Derm. 82, 537 (1960).
Russell, B., and H. Haber: An unusual case of necrobiosis. Brit. J. Derm. 66, 326 (1954).
Sachs, P.: In der Diskussion zu C. R. Rein u. N. B. Kanof, Necrobiosis lipoidica. Arch. Derm. Syph. (Chicago) 61, 130 (1950).
Savitt, L. E.: Favorable response of necrobiosis lipoidica diabeticorum to hydrocortisone suspension. A.M.A. Arch. Derm. Syph. 71, 506 (1955).
Smith Jr., J. G.: Necrobiosis lipoidica. A.M.A. Arch. Derm. 74, 280 (1956).
Urbach, E.: Nekrobiosis lipoidica diabeticorum. In Handbuch der Haut- und Geschlechtskrankheiten, herausgeg. von J. Jadassohn, Bd. XII/2, S. 352. Berlin: Springer 1932.
Usher, B., and J. M. Rabinowitch: Necrobiosis lipoidica diabeticorum. Arch. Derm. Syph. (Chicago) 35, 180 (1937).
Wile, U. J.: Necrobiosis without diabetes. Arch. Derm. Syph. (Chicago) 36, 912 (1937).
Winer, L. H.: In der Diskussion zu C. W. Laymon u. I. Fisher: Arch. Derm. Syph. (Chicago) 59, 150 (1949).
Wood, M. G., and H. Beerman: Necrobiosis lipoidica, granuloma annulare, and rheumatoid nodule. J. invest. Derm. 34, 139 (1960).
Zeisler, E. P., and M. R. Caro: Necrobiosis lipoidica diabeticorum (Urbach). Arch. Derm. Syph. (Chicago) 29, 167 (1934).
B, III, 2. Extracelluläre Cholesterinose (S. 149)
Degos, R., L. Perin, E. Lortat-Jacob et J. Hewitt: Erythema elevatum diutinum avec infiltrations lipoidiques au cours d’une affection bulleuse type Duhring. Bull. Soc. franç. Derm. Syph. 62, 226 (1952).
Frost, R., and C.R. Anderson: Extracellular cholesterosis of Urbach. Arch. Derm. Syph. (Chicago) 89, 1061 (1939).
Haber, H.: Erythema elevatum diutinum. Brit. J. Derm. 67, 121 (1955).
Herzberg, J. J.: Die extracelluläre Cholesterinose (Kerl-Urbach), eine Variante des Erythema elevatum diutinum. Arch. klin. exp. Derm. 205, 477 (1958).
Kerl, W.: Multiple Knotenbildungen, reichlich Lipoid enthaltend. Zbl. Haut- u. Geschl.-Kr. 37, 36 (1931).
Laymon, C. W.: Extracellular cholesterosis. Arch. Derm. Syph. (Chicago) 35, 269 (1937).
Sobel, N., and J. H. Pollock: Extracellular cholesterosis with pulmonary involvement. Arch. Derm. Syph. (Chicago) 58, 206 (1948).
Urbach, E.: Extracelluläre Cholesterinose. In Handbuch der Haut- und Geschlechtskrankheiten, herausgeg. von J. Jadassohn, Bd. XII/2, S. 320. Berlin: Springer 1932.
Urbach, E., E. Epstein u. K. Lorenz: Extrazelluläre Cholesterinose. Arch. Derm. Syph. (Berl.) 166, 243 (1932).
Weidman, F. D.: In der Diskussion zu E. W. Netherton, Chronic discoid lupus erythematosus with superimposed xanthomatous infiltration. Arch. Derm. Syph. (Chicago) 51, 100 (1945).
B, III, 3. Xanthelasma palpebrarum (S. 153)
Adlersberg, D., A. D. Parets and E. P. Boas: Genetics of atherosclerosis. J. Amer. med. Ass. 141, 246 (1949).
Curtis, A. C., and J. P. Berger: Effect of feeding a lipotropic substance to patients with xanthelasma. Arch. Derm. Syph. (Chicago) 52, 252 (1945).
Epstein, N. K, R. H. Rosenman and J. W. Gofman: Serum lipoproteins and cholesterol metabolism in xanthelasma. A.M.A. Arch. Derm. Syph. 65, 70 (1952).
Fowlkes, R. W., and J.C. Forbes: Cholesterol fractionation studies of the serum of xanthelasma patients. Arch. Derm. Syph. (Chicago) 62, 681 (1950).
Lever, W. F.: Hauterscheinungen bei Lipoidosen. Derm. Wschr. 132, 1086 (1955).
Montgomery, H.: In der Diskussion zu N. N. Epstein, R. H. Rosenman u. J. W. Gofman: A.M.A. Arch. Derm. Syph. (Chicago) 65, 70 (1952).
Polano, M. K.: Über die Pathogenese der Cholesterosen der Haut. Arch. Derm. Syph. (Berl.) 174, 213 (1936).
Polano, M. K.: Die Xanthelasmatosen der Haut. Arch. Derm. Syph. (Berl.) 181, 139 (1940).
Robinson, R. V. C.: Comparative incidence of xanthelasmata in Jews and Gentiles. A. M. A. Arch. Derm. Syph. (Chigaco). 70, 662 (1954).
B, III, 4. Naevoxanthoendotheliom (S. 154)
Arzt, L.: Beiträge zur Xanthom-(Xanthomatosis-)Frage. Arch. Derm. Syph. (Berl.) 126, 809 (1918).
Blank, H., P. G. Eglick and H. Beerman: Nevoxantho-endothelioma with ocular involvement. Pediatrics 4, 349 (1949).
Bloquiaux, S.: Naevo-xantho-endothéliomes. Arch. beiges Derm. 9, 202 (1953).
Crocker, A. C.: Skin xanthomas in childhood. Pediatrics 8, 573 (1951).
Greither, A., u. H. Tritsch: Die Geschwülste der Haut, S. 215. Stuttgart: Georg Thieme 1957.
Hassenpflug, K.: Naevoxanthoendotheliom oder jugendliches Histiozytom. Derm. Wschr. 136, 1347 (1957).
Helwig, E. B., and V. C. Hackney: Juvenile xanthogranuloma (nevoxanthoendothelioma). Amer. J. Path. 30, 625 (1954).
Jacobi, R., and J. L. Grund: Endothelioma cutis: Naevo-xantho-endothelioma. New Engl. J. Med. 202, 1247 (1930).
Köbner, H.: Xanthoma multiplex entwickelt aus Naevi vasculoso-pigmentosi. Vjschr. Derm. 3, 412 (1888).
Lamb, J. H., and E. S. Lain: Nevo-xantho-endothelioma. Its relation to juvenile xanthoma. Sth. med. J. 30, 585 (1937).
Laymon, C. W., and E. P. Schoch: Nevoxanthoendothelioma. Minn. Med. 32, 596 (1949).
Laymon, C. W., and E. P. Schoch: Le Coulant, Authié, Carles et Sustra: Sur un cas de naevo-xantho-endothéliome. Bull. Soc. franç. Derm. syph. 61, 182 (1954).
Lever, W. F.: Histiocytosis. A.M.A. Arch. Derm. 79, 608 (1959).
Maumenee, A. E.: Ocular lesions of nevoxantho-endothelioma (infantile xanthoma disseminatum). Trans. Amer. Acad. Ophthal. Otolaryng. 56, 401 (1956).
McDonagh, J. E. R.: A contribution to our knowledge of the naevo-xantho-endotheliomata. Brit. J. Derm. 24, 85 (1912).
Montgomery, H., and A. E. Österberg: Xanthomatosis. Correlation of clinical, histopathologic and chemical studies of cutaneous xanthoma. Arch. Derm. Syph. (Chicago) 37, 373 (1938).
Newell, F. W.: Nevoxanthoendothelioma with ocular involvement. A.M.A. Arch. Ophthal. (Chicago) 58, 321 (1957)
Nilsby, I.: Juvenile xanthoma. Acta paediat. (Uppsala) 41, 373 (1952).
Nödl, F.: Systematisierte großknotige Naevoxanthoendotheliome. Arch. klin. exp. Derm. 208, 601 (1959).
Nomland, R.: Nevoxantho-endothelioma. J. invest. Derm. 22, 207 (1954).
Polano, M. K.: Die Xanthelasmatosen der Haut. Arch. Derm. Syph. (Berlin)181, 139 (1940).
Senear, F. E., and M. R. Caro: Nevoxantho-endothelioma or juvenile xanthoma. Arch. Derm. Syph. 34,195 (1936).
Soehring, K.: Über Xanthelasmatose im frühen Kindesalter. Mschr. Kinderheilk. 77, 315 (1939).
Thannhauser, S. J.: Lipidoses, 3. Aufl., S. 362 u. 442. New York: Grüne u. Stratton 1958.
Thelander, H. E.: Xanthomatosis. J. Pediat. 34, 490 (1949).
Urbach, E.: Xanthelasma, Xantheloid und Xanthom. In Handbuch der Haut- und Geschlechtskrankheiten, herausgeg. von J. Jadassohn, Bd. XII/2, S. 264. Berlin: Springer 1932.
Wise, F.: Multiple endothelioma of skin. Amer. J. Med. Sci. 157, 236 (1919).
C. Gicht (S. 159)
Bauer, W., and F. Klemperer: Gout. In Diseases of Metabolism, herausgeg. von G. G. Duncan, 3. Aufl., S. 683. Philadelphia: W. B. Saunders 1683.
Benedict, J. D., P. H. Forsham and D. Stetten Jr.: The metabolism of uric acid in the normal and gouty human studied with the aid of isotopic uric acid. J. biol. Chem. 181, 183 (1949).
Benedict, J. D., T. F. Yü, E. J. Bien and D. Stetten Jr.: A further study of the utilization of dietary glycine nitrogen for uric acid synthesis in gout. J. clin. Invest. 32, 775 (1953).
Bishop, C., R. Rand and J. H. Talbott: Rate of conversion of isotopic glycine to uric acid in the normal and gouty human and how this is affected by vitamin E and folic acid. Metabolism 4, 174 (1955).
Brochner-Mortensen, K.: One hundred gouty patients. Acta med. scand. 106, 81 (1941).
Brown, J., and G. K. Mallory: Renal changes in gout. New Engl. J. Med. 243, 325 (1950).
Bunim, J. J., and C. McEwen: Tophus of the mitral valve in gout. Arch. Path. (Chicago) 29, 700 (1940).
Christopher, F., and S. E. Monroe: Tophi of the heels. J. Amer. med. Ass. 110, 2149 (1938).
Coombs, F. S., L. J. Pecora, E. Thorogood, W. V. Consolazio and J. H. Talbott: Renal function in patients with gout. J. clin. Invest. 19, 525 (1940).
Galantha, E. de: Technic for preservation and microscopic demonstration of nodules in gout. Amer. J. clin. Path. 5, 165 (1935).
Gottron, H. A., u. G. W. Körting: Chronische Hautgicht. Arch. klin. exp. Derm. 204, 483 (1957).
Grün, E.: Zur Histologie der Gichtknoten. Arch. Derm. Syph. (Berl.) 152, 3 (1926).
Gutman, A. B.: Uric acid metabolism and gout. Amer. J. Med. 9, 799 (1950).
Gutman, A. B.: Primary and secondary gout. Ann. intern. Med. 39, 1062 (1953).
Gutman, A. B., and T. F. Yü: Prevention and treatment of chronic gouty arthritis. J. Amer. med. Ass. 157, 1096 (1955).
Gutman, A. B., T. F. Yu, H. Black, R. S. Yalow and S. A. Berson: Incorporation of glycine- 1-C14, glycine-2-C14 and glycine-N15 into uric acid in normal and gouty subjects. Amer. J. Med. 25, 917 (1958).
Hench, P. S.: The diagnosis of gout and gouty arthritis. Proc. Mayo Clin. 11, 476 (1936).
Hoffman, W. S.: Metabolism of uric acid and its relation to gout. J. Amer. med. Ass. 154, 213 (1954).
Kaiser, L.: Primäre Hautgicht. Multiple kleinste bis hirsekorngroße Hauttophi der Volarselte der Finger. Arch. Derm. Syph. (Berl.) 151, 386 (1926).
Koskoff, Y. D., L. E. Morris and L. G. Lubis: Paraplegia as a complication of gout. J. Amer. med. Ass. 152, 37 (1953).
Lever, W. F., E. L. Schultz and N. A. Hurley: Plasma proteins in various diseases of the skin. A.M.A. Arch. Derm. Syph. 63, 702 (1951).
Levin, M. H., J. B. Rivo and S. H. Bassett: Metabolic studies in gout with emphasis on the role of the pituitary-adrenal axis in acute goutry arthritis. Ann. Rheumat. Dis. 11, 295 (1952).
Lichtenstein, L., H. W. Scott and M. H. Levin: Pathologic changes in gout. Amer. J. Path. 32, 871 (1956).
Lutz, W.: Stoffwechsel und Haut. In Handbuch der Haut- und Geschlechtskrankheiten, herausgeg. von J. Jadassohn, Bd. 3, S. 255 und 302. Berlin: Springer 1929.
McCracken, J. P., P. S. Owen and J.H. Pratt: Gout: Still a forgotten disease. J. Amer. med. Ass. 131, 367 (1946).
Muller, A. F., and W. Bauer: Uric acid production in normal and gouty subjects, determined by N15 labeled glycine. Proc. Soc. exp. Biol. (N.Y.) 82, 47 (1953).
Romeis, B.: Mikroskopische Technik. Nr 2137. Leibnitz 1948.
Ropes, M. W., G. E. Perlmann, D. Kaufman and W. Bauer: The electrophoretic distribution of proteins in plasma in rheumatoid arthritis. J. clin. Invest. 33, 311 (1954).
Ropes, M. W., E. Rossmeisl u. W. Bauer: The relationship between the erythrocyte sedimentation rate and the plasma proteins. J. clin. Invest. 18, 791 (1939).
Seegmiller, J. E., L. Laster and L. V. Llddle: Failure to detect consistent over-incorporation of glycine 1-C14 into uric acid in primary gout. Metabolism 7, 376 (1958).
Sherman, M.S.: Pathologic changes in gout. Arch. Path. (Chicago) 42, 557 (1946).
Stecher, R. M., A. H. Hersh and W. M. Solomon: The heredity of gout and its relationship to familial hyperuricemia. Ann. intern. Med. 31, 595 (1949)
Talbott, J. H.: Serum urate in the relatives of gouty patients. J. clin. Invest. 19, 645 (1940).
Talbott, J. H.: Gout, p. 23. New York: Grune u. Stratton 1957.
Thannhauser, L. J.: Über die Pathogenese der Gicht. Dtsch. med. Wschr. 81, 492 (1956).
Traut, E. F., A. A. Knight, P. B. Szanto and E. W. Passerelli: Specific vascular changes in gout. J. Amer. med. Ass. 156, 591 (1954).
Wyngaarden, J. B.: Overproduction of uric acid as the cause of hyperuricemia in gout. J. clin. Invest. 36,1508 (1957).
Wyngaarden, J. B.: Gout. In: The metabolic base of inherited disease, herausgeg. von J. B. Stanbury, J. B. Wyngaarden und D. S. Fredrickson, S. 679. New York: McGraw-Hill 1960.
Zöllner, N.: Die Behandlung der Gicht. Dtsch. med. Wschr. 81, 1997 (1956).
D. Ochronose (S. 166)
Black, R. L.: Use of cortisone in alkaptonuria. J. Amer. med. Ass. 155, 968 (1954).
Black, R. L., J. F. Lowry and P. M. Duffy: Alcaptonuria and ochronosis. Report of five cases occurring in an American Family. A.M.A. Arch. intern. Med. 93, 75 (1954).
Brogren, N.: Case of exogenic ochronosis from carbolic acid compresses. Acta derm.-venereol. (Stockh.) 32, 258 (1952).
Bürger, M., u. W. Schulze: Osteoarthropathia und Osteoporosis alcaptonurica. Dtsch. Z. Verdau.- u. Stoffwechselkr. 13, 49 (1953).
Coodley, E.L.,and A. J. Greco: Clinical aspects of ochronisis. Amer. J. Med. 8, 816 (1950).
Eisenberg, H.: Alkaptonuria, ochronosis, arthritis and ruptured intervertebral disk. Arch. intern. Med. 86, 79 (1950).
Fishberg, E.H.: The instantaneous diagnosis of alkaptonuria on a single drop of urine J. Amer. med. Ass. 119, 882 (1942).
Fleck, F.: Zur Symptomatik und Entstehung der endogenen Ochronose. Derm. Wschr. 134, 1317 (1956).
Friderich, H., u. W. Nikolowski: Endogene Ochronose. Arch. Derm. Syph. (Berl.) 192, 273 (1951).
Galdston, M., J. M. Steele and K. Dobriner: Alcaptonuria and ochronosis. With a report of three patients and metabolic studies in two. Amer. J. Med. 13, 432 (1952).
Hench, P. S.: Rheumatism and arthritis: Review of American and English literature of recent years (9th rheumatism review). Ann. intern. Med. 28, 309 (1948).
Hertzberg, J.: On osteoarthrosis alkaptonurica (ochronotica) with description of one case. Acta radioi. (Stockh.) 26, 484 (1945).
Hogben, L., R. L. Worall and I. Zieve: The genetic basis of alkaptonuria. Proc. roy. Soc. Edinb. 52, 264 (1931/32).
Kaufmann, E.: Die pathologischen Pigmentierungen der Haut in innerer Medizin, Neurologie und Psychiatrie. In Handbuch der Haut- und Geschlechtskrankheiten, herausgeg. von J. Jadassohn, Bd. IV, Teil 2, S. 1011. Berlin: Springer 1933.
Klein, O., u. K. Bloch: Beseltigung der Alkaptonurie durch parenterale Zufuhr von Leberextrakten. Klin. Wschr. 15, 1684 (1939).
Lanyar, F.: Über den Abbau der d- und 1-Form des Phenylalanins und der d,l- und 1-Form des Tyrosins durch den Alkaptonuriker. Hoppe-Seylers Z. physiol. Chem. 275, 217 (1942).
Laymon, C. W.: Ochronosis. Arch. Derm. Syph. (Chicago) 67, 553 (1953).
Martin, W. J., L. O. Underdahl and D. R. Mathieson: Alkaptonuria: report of three cases. Proc. Mayo Clin. 27, 193 (1952).
Pieter, H.: Une famille d’alcaptonuriques. Presse méd. 33, 1310 (1925).
Pomeranz, M. M., L.J. Friedman and I. S. Tunick: Roentgen findings in alkaptonurie ochronosis. Radiology 37, 295 (1941).
Ravdin, R. G., and D. I. Crandall: The enzymatic conversion of homogentisic acid to 4-fumarylacetoacetic acid. J. biol. Chem. 189, 137 (1951).
Skinsnes, O.K.: Generalized ochronosis. Arch. Path. (Chicago) 45, 552 (1948).
Smith, J. W.: Ochronosis of the sclera and cornea complicating alkaptonuria. J. Amer, med. Ass. 120, 1282 (1942).
Steele, J. M., K. Dobriner and M. Galdston: Studies of homogentisic acid production in a case of alkaptonuria. J. clin. Invest. 19, 792 (1940).
Young, H. H.: Calculi of the prostate associated with ochronosis and alkaptonuria. J. Urol. (Baltimore) 51, 48 (1944).
E, I. Metastatische Kalkablagerungen (S. 173)
Albright, F., and E. C. Reifenstein Jr.: The parathyroid glands and metabolic bone disease. Baltimore: Williams u. Wilkins 1948.
Bass, M. R., and J. Pakter: Congenital polycystic kidneys with secondary bone changes (Renal hyperparathyroidism; renal rickets). J. Mt. Sinai Hosp. 4, 882 (1938).
Bauer, J. M., and R. H. Freyberg: Vitamin D intoxication with metastatic calcification. J. Amer, med. Ass. 130, 1208 (1946).
Bevans, M., and H. K. Taylor: Lesions following the use of Ertron in rheumatoid arthritis. Amer. J. Path. 23, 367 (1947).
Burkholder, T. M., and R. R. Bratind: Massive calcinosis with chronic renal insufficiency due to polycystic kidneys; a case report. J. Urol. (Baltimore) 57, 1001 (1947).
Burnett, C. H., R. R. Commons, F. Albright and J. E. Howard: Hypercalcemia without hypercalcuria or hypophosphatemia, calcinosis and renal insufficiency. A syndrome following prolonged intake of milk and alkali. New Engl. J. Med. 240, 787 (1949).
Burnett, C. H., R. R. Commons, F. Albright and J. E. Howard: Case Records of Massachusetts General Hospital, Case 36371. New Engl. J. Med. 243, 418 (1950).
Castleman, B., and T. B. Mallory: The pathology of the parathyroid gland in hyperparathyroidism. Amer. J. Path. 11, 1 (1935).
Castleman, B., and T. B. Mallory: Parathyroid hyperplasia in chronic renal insufficiency. Amer. J. Path. 13, 553 (1937).
Christensen, W. R., C. Liebman and M. C. Sosman: Skeletal and periarticular manifestations of hypervitaminosis D. Amer. J. Roentgenol. 65, 27 (1951).
Creveld, S. van: Disturbances of metabolism in Besnier-Boeck’s disease. Ann. paediat. (Basel) 157, 1 (1941).
Curtis, L. E., and A. E. Feller: Hyperparathyroidism with calcinosis and secondary to renal disease; report of a probable case. Ann. intern. Med. 17, 1005 (1942).
Danowski, F. S., A.W. Winkler and J.P. Paters: Tissue calcification and renal failure produced by massive dose vitamin D therapy of arthritis. Ann. intern. Med. 23, 22 (1945).
Dreskin, E. A., and T. A. Fox: Adult renal osteitis fibrosa with metastatic calcification and hyperplasia of one parathyroid gland. Arch. intern. Med. 86, 533 (1950).
Fleischner, F. G., and S. R. Shalek: Conjunctival and corneal calcification in hypercalcemia. New Engl. J. Med. 241, 863 (1949).
Grayzel, D.M., and M. Lederer: Metastatic calcification. Arch. intern. Med. 64, 136 (1939).
Hanes, F. M.: Hyperparathyroidism due to parathyroid adenoma, with death from parathormone intoxication. Amer. J. med. Sci. 197, 85 (1939).
Henneman, P. H., and W.H. Baker: Two mechanisms of sustained hypercalcemia following hypervitaminosis D and the milk-alkali syndrome. J. clin. Invest. 36, 899 (1957).
Henneman, P. H., E. F. Dempsey, E. L. Carroll and F. Albright: The cause of hypercalcuria in sarcoid and its treatment with cortisone and sodium phytate. J. clin. Invest. 35, 1229 (1956).
Herbert, F. K., H. G. Miller and G. O. Richardson: Chronic renal disease, secondary parathyroid hyperplasia, decalcification of bone and metastatic calcification. J. Path. Bact. 53, 161 (1941).
Hubbard, R. S., and J. A. Wentworth: A case of metastatic calcification associated with chronic nephritis and hyperplasia of the parathyroids. Proc. Soc. exp. Biol. (N.Y.) 18, 307 (1921).
Jadassohn, J.: Über „Kalkmetastasen“ in der Haut. Arch. Derm. Syph. (Berl.) 100, 317 (1910).
Jackson, A., G. C. Bates, M. Slavin and M. D. McFarland: Renal osteodystrophy associated with diabetes mellitus. Arch. intern. Med. 85, 11 (1950).
Kaufman, M., and J. W. Dow: Hyperparathyroidism with calcinosis, probably secondary to renal disease. Lahey Clin. Bull. 5, 21 (1946).
Kerl, W.: Beiträge zur Kenntnis der Verkalkungen der Haut. Arch. Derm. Syph. (Berl.) 126, 172 (1918/19).
Klatskin, G., and M. Gordon: Renal complications of sarcoidosis and their relationship to hypercalcemia. Amer. J. Med. 15, 484 (1953).
Laubmann: Hochgradige Kalkmetastasierung bei Epithelkörperchentumor. Verh. dtsch. path. Ges. 27, 231 (1934).
Longcope, W. T., and D. G. Freiman: A study of sarcoidosis. Medicine (Baltimore) 31, 1 (1952).
Magnus, H.A., and R.B. Scott: Chronic renal destruction and parathyroid hyperplasia. J. Path. Bact. 42, 665 (1936).
Marsden, J. P.: Metastatic calcification; notes on twins born shortly after attack of smallpox in mother. Brit. J. Child. Dis. 27, 193 (1930).
Morgan, A.D., and N. F. Maclagan: Renal disease in hyperparathyroidism. Amer. J. Path. 30, 1141 (1954).
Mulligan, R. M.: Metastatic calcification associated with hyper-vitaminosis D and haliphagia. Amer. J. Path. 22, 1293 (1946).
Mulligan, R. M.: Metastatic calcification. Arch. Path. (Chicago) 43, 177 (1947).
Naegeli, O.: Kalkablagerungen. In Handbuch der Haut- und Geschlechtskrankheiten, herausgeg. von J. Jadassohn, Bd. IV/3, S. 358. Berlin: Springer 1932.
Penecke: Über zwei Fälle von Ostitis fibrosa Recklinghausen mit Epithelkörperchentumoren. Zbl. allg. Path. path. Anat. 37, 535 (1926).
Platt, R., and T. K. Owen: Renal dwarfism associated with calcification of arteries and skin. Lancet 1934II, 135.
Pollack, H., and S. Siegal: Parathyroid hyperplasia and calcinosis associated with renal disease. J. Mt Sinai Hosp. 2, 270 (1936).
Putkonen, T., and G. A. Wangel: Renal hyperparathyroidism with metastatic calcification of the skin. Dermatologica (Basel) 118, 127 (1959).
Schüpbach, A., u. M. Wernly: Hyperkalzämie und Organverkalkungen bei Boeckscher Krankheit. Acta med. scand. 115, 401 (1943).
Smyth, F. S., and L. Goldman: Renal rickets with metastatic calcification and parathyroid dysfunction. Amer. J. Dis. Child. 48, 596 (1934).
Soffer, L. J., and C. Coiin: Primary and secondary hyperparathyroidism. Arch. intern. Med. 71, 630 (1943).
Walsh, F. B., and J. E. Howard: Conjunctival and corneal lesions in hypercalcemia. J. clin. Endocr. 7, 644 (1947).
Weidman, F. D., and L. W. Shaffer: Calcification of the skin, including the epiderm in connection with extensive bone resorption. Arch. Derm. Syph. (Chicago) 14, 513 (1926).
Wells, H. G., and S. W. Holley: Metastatic calcification in osteitis deformans (Paget’s disease of the bone). Arch. Path. (Chicago) 34, 435 (1942).
Wermer, P., M. Kuschner and E. A. Riley: Reversible metastatic calcification associated with excessive milk and alkali intake. Amer. J. Med. 14, 108 (1953).
Wigley, J. E. M., and D. Hunter: Calcinosis in a case of chronic nephritis with secondary hyperparathyroidism. Proc. roy. Soc. Med. 38, 141 (1945).
Wilson, C. W., W. L. Wingfield and E. C. Toone Jr.: Vitamin D poisoning with metastatic calcification. Amer. J. Med. 14, 116 (1953).
E, II. Calcinosis cutis (S. 182)
Bauer, W., A. Marble and G.A. Bennett: Further studies in a case of calcification of subcutaneous tissue (”calcinosis universalis”) in a child. Amer. J. med. Sci. 182, 237 (1931).
Briggs, J. N., and R. S. Illingworth: Calcinosis universalis treated with adreno-corticotrophic hormone and cortisone. Lancet 1952 II, 800.
Brooks, W. D. W.: Calcinosis. Quart. J. Med. 27, 293 (1934).
Cornbleet, T., C. I. Reed and B. P. Reed: X-ray diffraction studies in calcinosis. J. invest. Derm. 13, 171 (1949).
Craig, J., and A. Lyall: Calcinosis universalis, suggested methods of treatment. Brit. J. Child. Dis. 28, 29 (1931).
Debré, R., P. Mozziconacci, J. Rivron et M. Goulon: Dermatomyosite à évolution lente avec calcifications, action favorable de l’A.C.T.H. Arch. franç, pédiat. 10, 619 (1953).
Epstein, E.: Idiopathic calcinosis cutis. Arch. Derm. Syph. (Chicago) 34, 367 (1936).
Forester, W. G., and W. W. Swanson: Calcinosis in a new-born infant. Amer. J. Dis. Child. 42, 1267 (1931).
Friedländer, J.: Untersuchungen des Gesamtmineralwechsels bei Calcinosis universalis. Dtsch. Arch. klin. Med. 166, 107 (1930).
Gomori, G.: Calcification and phosphatase. Amer. J. Path. 19, 197 (1943).
Hecht, M. S.: Dermatomyositis in childhood. J. Pediat. 17, 791 (1940).
Houston, C. J., and E. Johnson: A case of unusual calcium deposition due to Raynaud’s disease. Canad. med. Ass. J. 39, 60 (1938).
Kennedy, R. L. J.: Calcinosis and scleroderma; treatment of a case by use of the keto-genic diet. J. Pediat. 1, 667 (1932).
Marcus, M. D., and W. E. Wooldridge: Poikilodermatomyositis (Poikiloderma vasculare atrophicans). Arch. Derm. Syph. (Chicago) 62, 131 (1950).
Morse, J. L.: Calcification of the skin in a child. Amer. J. Dis. Child. 22, 412 (1921).
Naegeli, O.: Kalkablagerungen. In Handbuch der Haut- und Geschlechtskrankheiten, herausgeg. von J. Jadassohn, Bd. IV/3, S. 396. Berlin: Springer 1932.
Nitkin, R. L.: Soft tissue calcification in acrodermatitis chronica atrophicans. N.Y. St. J. Med. 41, 1663 (1941).
Obermayer, M. E., and K. B. Munt: Calcinosis. Arch. Derm. Syph. (Chicago) 32, 684 (1935).
O’Leary, P. A., and M. Waisman: Dermatomyositis: a study of forty cases. Arch. Derm. Syph. (Chicago) 41, 1001 (1940).
Peters, J. H., R.H.Horn and L. Greeman: Idiopathic calcinosis universalis cutis without disability. Ann. intern. Med. 32, 138 (1950).
Ponhold, J.: Zur Histologie der Kalkgicht. Arch. Derm. Syph. (Berl.) 182, 412 (1941).
Rothstein, J. L., and S. Welt: Calcinosis universalis and calcinosis circumscripta in infancy and in childhood. Amer. J. Dis. Child. 52, 368 (1936).
Rudolph, C. C.: Calcinosis universalis and dermatomyositis. J. Pediat. 4, 342 (1934).
Salvesen, H. A., and J. Böe: On calcinosis. Acta med. scand. 92, 389 (1937).
Schiff, B. L., and A. B. Kern: Metabolie calcinosis in the newborn. A.M.A. Arch. Derm. Syph. 68, 672 (1953).
Sheard Jr., C.: Dermatomyositis. A.M.A. Arch. intern. Med. 88, 640 (1951).
Sheldon, J. H.: Calcinosis universalis. Proc. roy. Soc. Med. 27, 623 (1933/34).
Silva, F., A. de A. Ponde and F. Lichtenberg: Poikilodermatomyositis with calcinosis cutis. Arch. Derm. Syph. (Chicago) 68, 588 (1953).
Skossogorenko, G. F.: Calcinosis interstitialis universalis. J. Bone u. Jt. Surg. 14, 339 (1932).
Spahr, A., u. H. Brenn: Die Calcinosis interstitialis bei Dermatomyositis. Helv. paediat. Acta 12, 48 (1957).
Steinitz, H.: Calcinosis circumscripta („Kalkgicht“) und Calcinosis universalis. Ergebn. inn. Med. Kinder-heilk. 39, 216 (1931).
Thibierge, G., et A. J. Weissenbach: Concrétions calcaires sous-cutanées et sclerodermic. Ann. Derm. Syph. (Paris) 2, 129 (1911).
Wedgwood, R. J. P., C. P. Cook and J. Cohen: Dermatomyositis. Report of 26 cases in children with a discussion of endocrine therapy in 13. Pediatrics 12, 447 (1953).
Weissenbach, R. J., G. Basch et M. Basch: Essai critique sur la pathogénie des concrétions calcaires des sclérodermies (syndrome de Thibierge-Weissenbach) et des syndromes voisins. Ann. Méd. 31, 504 (1932).
Wheeler, C. E., A. C. Curtis, E. P. Cawley, R. H. Grekin and B. Zheutlin: Soft tissue calcification, with special reference to its occurrence in the collagen diseases. Ann. intern. Med. 36, 1050 (1952).
Wilens, J., and J. Derby: Calcification of subcutaneous tissue in a child (calcinosis universalis). Amer. J. Dis. Child. 31, 34 (1926).
Wiskemann, A.: Calcinosis cutis universalis und Poikilodermie. Arch. Derm. Syph. (Berl.) 199, 507 (1955).
Zellweger, H.: Calcinosis interstitialis universalis bei Angiotrophoneurose. Helv. paediat. Acta 3, 287 (1948).
E, III. Dystrophische Kalkablagerungen (S. 188)
Finnerud, C. W., and R. Nomland: Pseudoxanthoma elasticum. Arch. Derm. Syph. (Chicago) 35, 653 (1937).
Gougerot, H., and Tabernat: Dermo-hypodermite calcifiante: granulome calcaire cutané. Ann. Derm. Syph. (Paris) 9, 300 (1949).
Grönblad, E.: Calcinosis cutis in pseudoxanthoma elasticum. Acta derm.-venereol. (Stockh.) 28, 270 (1948).
Holt, J. F.: The Ehlers-Danlos syndrome. Amer. J. Roentgenol. 55, 420 (1946).
Lindner, B.: Die Phlebitis als Ursache subkutaner Verkalkungen. Derm. Wschr. 125, 221 (1952).
Lindner, B.: Über disseminierte Unterschenkel-Hautverkalkungen (Calcinosis subcutanea postphlebitica). Arch. Derm. Syph. (Berl.) 196, 403 (1953).
Lobitz Jr., W. C., and A. E. Osterberg: Pseudoxanthoma elasticum: microincineration. J. invest. Derm. 15, 297 (1950).
Naegeli, O.: Kalkablagerungen. In Handbuch der Haut- und Geschlechtskrankheiten, herausgeg. von J. Jadassohn, Bd. IV/3, S. 423. Berlin: Springer 1932.
Rachold, H.: Über Knochenneubildung in der Subkutis beider Unterschenkel. Derm. Wschr. 99, 1141 (1934).
Steigleder, G. K., and H. Elschner: Lokalisierte Calcinosis. Hautarzt 8, 127 (1957).
Tannenhain, E.G. v.: Zur Kenntnis des Pseudoxanthoma elasticum (Darier). Wien, klin. Wschr. 14, 1038 (1901).
Tobias, N.: Danlos syndrome associated with congenital lipomatosis. Arch. Derm. Syph. (Chicago) 30, 540 (1934).
Weber, F. Parkes, and J. K. Aitken: Nature of the subcutaneous spherules in some cases of the Ehlers-Danlos syndrome. Lancet 19381, 198.
Wendlberger, J.: Dystrophische Verkalkungen bei einem Fall von Ulcus varicosum cruris. Derm. Wschr. 102, 50 (1936).
Winer, L. H.: Solitary congenital nodular calcification of the skin. A.M.A. Arch. Derm. Syph. (Chicago) 66, 204 (1952).
F. Porphyrien (S. 190)
Aldrich, R. A., V. Hawkinson,M. Grinstein and C.J. Watson: Photosensitive or congenital porphyria with hemolytic anemia. I. Clinical and fundamental studies before and after splenectomy. Blood 6, 685 (1951).
Aldrich, R. A., R. F. Labbe and E. L. Talman: A review of porphyrin metabolism with special reference to childhood. Amer. J. med. Sci. 230, 675 (1955).
Anderson, T. MacCall.: Hydroa aestivale in two brothers, complicated with the presence of haematoporphyrin in the urine. Brit. J. Derm. 10, 1 (1898).
Ashby, H. T.: Haematoporphyria congenita (congenital porphyrinuria): its association with hydroa vacciniforme and pigmentation of the teeth. Quart. J. Med. 19, 375 (1926).
Bazin, E.: Leçons théoriques et cliniques sur les affections génériques de la peau. Paris 1862.
Beerman, H., and T. Pastras: The porphyrias: a discussion of some current concepts. Amer. J. med. Sci. 235, 471 (1958).
Bergh, van den, A. A. Humans u. W. Grotepass: Ein bemerkenswerter Fall von Porphyrie. Wien. klin. Wschr. 50, 837 (1937).
Bergh, van den, A.A. Humans, Regniers u. Muller: Ein Fall von kongenitaler Porphyrinurie mit Koproporphyrin in Harn und Stuhl. Arch. Verdau.-Kr. 42, 302 (1928).
Bering, F., u. J. Barnewitz: Aktinische Dermatosen. Hydroa vacciniforme. In Handbuch der Haut-und Geschlechtskrankheiten, herausgeg. von J. Jadassohn, Bd. IV/1, S. 143. Berlin: Springer 1932.
Berman, J., u. T. Bielicky: Einige äußere Faktoren in der Ätiologie der Porphyria cutanea tarda und des Diabetes mellitus mit besonderer Berücksichtigung der syphilitischen Infektion und ihrer Behandlung. Dermatologica (Basel) 113, 78 (1956).
Blum, H. F., and N. Pace: Studies of photosensitization by porphyrins. Brit. J. Derm. Syph. 49, 464 (1937).
Bogorad, L.: The enzymatic synthesis of porphyrins from porphobilinogen. J. biol. Chem. 233, 516 (1958).
Bolgert, M., and J. Canivet: Cutaneous porphyria in the adult. Brit. J. Derm. 66, 312 (1954).
Bolgert, M., J. Canivet et J. Lépine: Lésions seléro-lichéniennes et scléro-vitiligineuses de la porphyrie cutanée de l’adulte. Ann. Derm. Syph. (Paris) 83, 142 (1956).
Bolgert, M., J. Canivet et M. LeSourd: Trois cas de porphyrie cutanée congénitale (maladie de Günther) dans la même fratrie. Bull. Soc. franç. Derm. Syph. 59, 233 (1952).
Borst, M., u. H. Königsdörffer: Untersuchungen Über Porphyrie mit besonderer Berücksichtigung der Porphyria congenita. Leipzig: S. Hirzel 1929.
Brugsch, J.: Melanodermie-Porphyrie (Porphyrie mit Melanodermie). Z. ges. inn. Med. 11, 5 (1956).
Brunsting, L. A.: Observations on porphyria cutanea tarda. A.M.A. Arch. Derm. Syph. 70, 551 (1954).
Brunsting, L. A., J. T. Brtjgsch and P. A. O’Leary: Quantitative investigation of porphyrin metabolism in diseases of the skin. Arch. Derm. Syph. (Chicago) 39, 294 (1939).
Brunsting, L. A., and H.L. Mason: Porphyria with cutaneous manifestations. Arch. Derm. Syph. (Chicago) 60, 66 (1949).
Brunsting, L. A., H. L. Mason and R. A. Aldrich: Adult form of chronic porphyria with cutaneous manifestations. J. Amer. med. Ass. 146, 1207 (1951).
Caletti, G.: Luciti a tipo epidermolisi bullosa con porfiria. G. ital. Derm. Sif. 89, 187 (1948).
Calvert, R. J., and C. Rimington: Porphyria cutanea tarda in relapse: a case report. Brit. med. J. 1953II, 1131.
Calvy, G. L., and C. C. Dundon: Roentgen manifestations of acute intermittent porphyria. Radiology 58, 204 (1952).
Calvy, G. L., E. J. Jaruszewski and H. H. Carroll: Porphyria: clinical observations and a family vignette. Ann. intern. Med. 34, 767 (1951).
Capelli, J.: Caso singolare di hydroa vacciniforme con ematoporfirinuria ed ipertricosi. G. ital. Mal. vener. 55, 481 (1914).
Comfort, A., H. Moore and M. Weatherall: Normal human urinary porphyrins. Biochem. J. 58, 177 (1954).
Cornbleet, T.: Cutaneous appearance of porphyria by ultraviolet light. A.M.A. Arch. Derm. 73, 34 (1956).
Coulonjou, R., J. Pouderout et E. Derouet: Porphyrie aigue intermittente grave avec séquelles neurologiques: action favorable du 4560 RP. Rev. neurol. 88, 122 (1953).
Dannenberg, H., u. H. Reinwein: Zur Klinik der Porphyria cutanea tarda. Dtsch. Arch. klin. Med. 202, 214 (1955).
Davis, M. J., u. D. E. van der Ploeg: Acute porphyria and coproporphyrinuria following chloroquine therapy. A.M.A. Arch. Derm. 75, 796 (1957).
Dean, G., and H. D. Barnes: The inheritance of porphyria. Brit. med. J. 1955II, 89.
Dillaha, C. J., and W. Hicklin: Experimental therapy of chronic porphyria with vitamin B12. J. invest. Derm. 19, 489 (1952).
Discombe, G., and C. S. Treip: Cutaneous manifestations of porphyria. Brit. med. J. 1953II, 1134.
Dobriner, K., W. H. Strain, H. Guild and S. A. Localio: The excretion of porphyrins in congenital porphyria. J. clin. Invest. 17, 761 (1938).
Dunsky, I., S. Smith-Freeman and S. Gibson: Porphyria and porphyrinuria. Amer. J. Dis. Child. 74, 305 (1947).
Ehrmann, S.: Weitere Untersuchungen Über Lichtwirkung bei Hydroa aestivalis (Bazin) und Sommereruption (nach Hutchinson). Arch. Derm. Syph. (Berl.) 97, 75 (1909).
Feldaker, M., H. Montgomery and L. A. Brtjnsting: Histopathology of porphyria cutanea tarda. J. invest. Derm. 24, 131 (1955).
Findley, G. H., and H.D. Barnes: Congenital porphyria, hydroa aestivale and hypertrichosis in a South African Bantu. Lancet 1950II, 846.
Fischer, H.: Über das Uroporphyrin. Hoppe-Seylers Z. physiol. Chem. 95, 34 (1915). —
Fischer, H.: Über das Kotporphyrin. Hoppe-Seylers Z. physiol. Chem. 96, 148 (1915).
Fischer, H.: Farbstoffe mit Pyrrolkernen. In: Handbuch der Biochemie des Menschen und der Tiere. Herausgeg. von C. Oppenheimer. 2. Aufl., Bd. I, S. 351. Jena: Gustav Fischer 1924.
Fischer, H., H. Hilmer, F. Lindner u. B. Pützer: Zur Kenntnis der natürlichen Porphyrine. XVIII. Mitteilung. Chemische Befunde bei einem Fall von Porphyrinurie (Petry). Hoppe-Seylers Z. physiol. Chem. 150, 44 (1925).
Garcin, R., et J. Lapresle: Manifestations nerveuses des porphyries. Sem. Hôp. Paris 26, 3404 (1950).
Gibson, K. D., A. Neuberger and J. J. Scott: The enzymatic conversion of δ-aminolevulinic acid to porphobilinogen. Biochem. J. 58, xli (1954).
Gottron, H. A., u. F. Ellinger: Beitrag zur Klinik der Porphyrie. Arch. Derm. Syph. (Berl.) 164, 11 (1931).
Gottron, H. A., u. F. Ellinger: Klinische und experimentelle Befunde bezüglich der Reaktion des Gefäßbindegewebesapparates der Haut bei der Porphyrie. Arch. Derm. Syph. (Berl.) 167, 325 (1933).
Granick, S.: Porphyrin biosynthesis in erythrocytes. I. Formation of -aminolevulinic acid in erythrocytes. J. biol. Chem. 232, 1101 (1958).
Granick, S., u. D. Mauzerall: Porphyrin biosynthesis in erythrocytes. II. Enzymes converting -aminolevulinic acid to co-proporphyrinogen. J. biol. Chem. 232, 1119 (1958).
Granick, S., u. H. G. V. van den Schrieck: Porphobilinogen and δ-amino levulinic acid in acute porphyria. Proc. Soc. exp. Biol. (N.Y.) 88, 270 (1955).
Gray, A. M. H.: Haematoporphyria congenita with hydroa vacciniforme and hirsuties. Quart. J. Med. 19, 381 (1926).
Gray, C. H.: Acute porphyria. Report of a case. Arch. intern. Med. 85, 459 (1950).
Gray, C. H., M. H. Muir and A. Neiberger: Studies in congenital porphyria. Biochem. J. 47, 542 (1950).
Gray, C. H., and A. Neuberger: Investigations on porphyrin formation in congenital porphyria with the aif of15N. Biochem. J. 44, xlv (1949).
Gray, C. H., and A. Neuberger: Studies in congenital porphyria. I. Incorporation of 15N into coproporphyrin, uroporphyrin and hippuric acid. Biochem. J. 47, 81 (1950).
Gray, C. H., C. Rimington and S. Thomson: A case of chronic porphyria associated with recurrent jaundice. Quart. J. Med. 17, 123 (1948).
Grinstein, M., S. Schwartz and C. J. Watson: Studies of the uroporphyrins. I. The purification of uroporphyrin I and the nature of Waldenstrom’s uroporphyrin, as isolated from porphyria material. J. biol. Chem. 157, 323 (1945).
Günther, H.: Die Hämatoporphyrie. Dtsch. Arch. klin. Med. 105, 89 (1911).
Günther, H.: Die Bedeutung der Hämatoporphyrine in Physiologie und Pathologie. Ergebn. allg. Path. path. Anat. 20, 608 (1922).
Hamminga, H.: Porphyria with light sensitivity. Ned. T. Geneesk. 95, 696 (1951).
Hausmann, W.: Die sensibilisierende Wirkung tierischer Farbstoffe und ihre physiologische Bedeutung. Wien. klin. Wschr. 22, 1820 (1909).
Hernando, T.: La porphyrie: ses manifestations digestives, cutanées et oculaires. Biol. med. (Paris) 36, 293 (1938).
Hoppe-Seyler, F.: Hämatoporphyrine. Med. chem. Untersuch. 4, 523 (1871).
Ippen, H.: Zur Pathogenese der Porphyria cutanea tarda. Arch. klin. exp. Derm. 212, 467 (1961).
Kark, R. M.: Clinical aspects of the major porphyrinopathies. Med. Clin. N. Amer. 39, 11 (1955).
Kimmig, J.: Lichtdermatosen und Lichtschutz. Arch. Derm. Syph. (Berl.) 200, 68 (1955).
Kitagawa, K.: Über Hämatoporphyria congenita „Hans Günther“ und ihre experimentelle Untersuchung. Jap. J. Derm. Urol. 27, 43 (1927).
Kosenow, W.: Erythrocyten-Primärfluoreszenz bei Porphyrin-Dermatosen. Med. Klin. 49, 1099 (1954).
Kosenow, W.: Zur Diagnostik der Porphyrin-Dermatosen. Arch. Derm. Syph. (Berl.) 200, 89 (1955).
Kuske, H.: Zum Problem der Hautveränderungen bei Porphyrie. Dermatologica (Basel) 92,149 (1946).
Lageder, K.: Klinische Porphyrinuntersuchungen mit einer quantitativen spektroskopischen Methode. Arch. Verdau.-Kr. 56, 237 (1934).
Langhof, H., u. G. Mildschlag: Aktinisch-traumatisch-bullöse Porphyrindermatose kombiniert mit beginnender Hämo-chromatose. Arch. Derm. Syph. (Berl.) 199, 21 (1954).
Langhof, H., H. Müller u. L. Rietschel: Untersuchungen zur familiären, protoporphyrinämischen Lichturticaria. Arch. klin. exp. Derm. 212, 506 (1961).
Leonhardi, G., u. M. Baier: Die cutane Form der hepatischen Porphyrie und die Porphyrinausscheidung im Harn. Arch. klin. exp. Derm. 207, 554 (1958).
Linden, I. H., C. G. Steffen, V. D. Newcomer u. M. Chapman: Development of porphyria during chloroquine therapy for chronic discoid lupus erythematosus. Calif. Med. 81, 235 (1954).
Linser, P.: Über den Zusammenhang zwischen Hydroa aestivale und Hämatoporphyrie. Arch. Derm. Syph. (Berl.) 79, 251 (1906).
London, I. D.: Porphyria cutanea tarda. Report of a case successfully treated with chloroquine. A.M.A. Arch. Derm. 75, 801 (1957).
London, I. M., R. West,D. Shemin and D. Rittenberg: Porphyrin formation and hemoglobin metabolism in congenital porphyria. J. biol. Chem. 184, 365 (1950).
MacGregor, A. G., R. E. H. Nicholas and C. Rimington: Porphyria cutanea tarda. A.M.A. Arch. intern. Med. 90, 483 (1952).
Mackey, L., and A. E. Garrod: A further contribution to the study of congenital porphyrinuria (Haematoporphyria congenita). Quart. J. Med. 19, 357 (1926).
Marcozzi, A.: Epidermolisi bullosa distrofica con matoporfirin-uria ed alterazione endocrino-simpatica (Eritrodontia). Arch. ital. Derm. 4, 555 (1929).
Markovitz, M.: Acute intermittent porphyria: a report of five cases and a review of the literature. Ann. intern. Med. 41, 1170 (1954).
Martin, W. J., and F. J. Heck: The porphyrins and porphyria. A review of eighty-one cases. Amer. J. Med. 20, 239 (1956).
Marval, L. de, Y. R. Pons: Concomitancia entre una porfirinuria congenita en ictericia hemolitica. Esplanectomia. Arch. argent. Pediat. 5, 220 (1934).
Matstjoka, K.: Über Haematoporphyria congenita. Jap. J. Derm. 28, 38 (1926).
Mauzerall, D.,u. S. Granick: Porphyrin biosynthesis in erythrocytes. III. Uroporphyrinogen and its decarboxylase. J. biol. Chem. 232, 1141 (1958).
May, E., M. Bloch-Michel, Poncet-Guaret et P. Tournier: Porphyrie familiale (maladie de Günther). Bull. Soc. méd. Hop. Paris 64, 340 (1948).
McFarland, A. R., and W. H. Strain: Significance of porphyrin content of urine in dermatoses associated with sensitivity to light. Arch. Derm. Syph. (Chicago) 38, 727 (1938).
Meineri, A.: Sindrome cutanea a tipo di epidermolisi bullosa, a di idroa vacciniforme con porfiria. Dermosifilografo 6, 389 (1931).
Melby, J. C., J. P. Street and C. J. Watson: Chlorpromazine in the treatment of porphyria. J. Amer. med. Ass. 162, 174 (1956).
Menagh, F., and C. E. Reyner: Hydroa aestivale: congenital porphyria. A.M.A. Arch. Derm. Syph. 63, 518 (1951).
Merkelbach, O.: Porphyrie I (cutané und abdominelle Form). Schweiz, med. Wschr. 24, 1182 (1943).
Mertens, E.: Über die bei akuter Porphyrie auftretenden Porphyrine. Hoppe-Seylers Z. physiol. Chem. 250, 57 (1937).
Meyer-Betz, F.: Untersuchungen Über die biologische (photodynamische) Wirkung des Hämatoporphyrins und anderer Derivate des Blut- und Gallenfarbstoffes. Dtsch. Arch. klin. Med. 112, 476 (1913).
Michelson, H. E.: Hydroa aestivale and porphyrin dermatoses. A.M.A. Arch. Derm. Syph. 71, 628 (1955).
Minden, H.: Beitrag zur Diagnostik der Porphyria cutanea tarda. Z. ges. inn. Med. 11, 232 (1956).
Monaco, R. N., R. D. Leeper, J. J. Robbins and G. L. Calvy: Intermittent acute porphyria treated with chlorpromazine. New Engl. J. Med. 256, 309 (1957).
Nencki, M., u. N. Sieber: Über das Hämatoporphyrin. Naunyn-Schmiedeberg’s Arch. exp. Path. Pharmak. 24, 430 (1888).
Nesbitt, L., and C. H. Watkins: Acute porphyria. Amer. J. med. Sci. 203, 74 (1942).
Nicholas, R. E. H.: Chromatographic methods for the separation and identification of porphyrins. Biochem. J. 48, 309 (1951).
Nicholas, R. E. H., and C. Remington: Paper chromatography of porphyrins: some hitherto unrecognized porphyrins and further notes on the method. Biochem. J. 48, 306 (1951).
Nicholas, R. E. H., and C. Remington: Studies on the Waldenstrom porphyrin of acute porphyria urines. Biochem. J. 55, 109 (1953).
Ottolenghi-Lodigiani, F., e G. Serchi: Le porfirine ed il loro metabolismo nella porfiria congenita. G. ital. Dermat. Sif. 89, 187 (1948).
Paul, K. G., A. Engström and B. Engfeldt: Localization of porphyrins in bone tissue in a case of porphyria cutanea tarda. J. clin. Path. 6, 135 (1953).
Paul, K. G., and N. Thyresson: The effect of BAL on a case of ”cutaneous porphyria”. Acta derm.-venereol. (Stockh.) 84, 403 (1954).
Peachey, C. H., K. Dobriner and W. H. Strain: Hydroa estivale in congenital porphyria. N.Y. St. J. Med. 38, 848 (1938).
Perry, H. O., and L. A. Brunsting: Porphyria cutanea tarda simulating dermatitis factitia. A.M.A. Arch. Derm. 74, 198 (1956).
Peters, H. A., S. Woods, P. L. Eichman and H. H. Reese: The treatment of acute porphyria with chelating agents: a report of 21 cases. Ann. intern. Med. 47, 889 (1957).
Pozzan, M.:Porfiria congenita con iperemolisi. Acta paediat. matina 6, 995 (1953).
Prunty, F. T. G.: Acute porphyria: Investigations on pathology of porphyrins and identification of excretion of uroporphyrin I. Arch. intern. Med. 77, 623 (1946).
Radaeli, F.: Contributo alia conoscenza dell’ hydroa vacciniforme di Bazin. G. ital. Mal. vener. 52, 93 (1911).
Rimington, C.: Haems and porphyrins in health and disease, II. Acta med. scand. 143, 177 (1952).
Robert, P.: Epidermolysis bullosa dystrophica-artige Dermatose bei kongenitaler Porphyrinurie. Dermatologica (Basel) 97, 106 (1948).
Sato, A., and H. Takahashi: A new form of congenital hematoporphyria: oligochromemia porphyrinuria (megalosplenica, congenita). Amer. J. Dis. Child. 32, 325 (1926).
Schmid, R.: The porphyrias. In: The metabolic base of inherited disease, herausgeg. von J. B. Stanbury, J. B. Wyngaarden u. D. S. Fredrickson, S. 939. New York: McGraw-Hill 1960.
Schmid, R., S. Schwartz and R. D. Sundberg: Erythropoetic (congenital) porphyria: a rare abnormality of the normoblasts. Blood 10, 416 (1955).
Schmid, R., S. Schwartz u. C. J. Watson: Neuere Ergebnisse auf dem Gebiete der Porphyrien. Acta haemat. (Basel) 10, 150 (1953).
Schmid, R., S. Schwartz u. C. J. Watson: Porphyrin content of bone marrow and liver in the various forms of porphyria. A.M.A. Arch. intern. Med. 93, 167 (1954).
Schmidt, P. R.: Neurologische und psychische Störungen bei Porphyrinkrankheiten. Fortschr. Neurol. Psychiat. 20, 422 (1952).
Schmidt-LaBaume, F.: Ein besonders exzessiver Fall von Hydroa vacciniforme. Arch. Derm. Syph. (Berl.) 153, 368 (1927).
Schreus, H. Th., u. C. Carrie: Beobachtungen bei einem Fall von kongenitaler Porphyrie. Derm. Z. 62, 347 (1931).
Schrumpf, A.: Porphyria improved after treatment with BAL. Acta med. scand. 145, 338 (1953).
Schwartz, S.: Porphyrin and heme synthesis. Fed. Proc. 13, 293 (1954).
Schwartz, S., and C. J. Watson: Isolation of uroporphyrin from the feces in idiopathic porphyria. Proc. Soc. exp. Biol. (N.Y.) 47, 390 (1941).
Shemin, D., I. M. London and D. Rittenberg: The synthesis of protoporphyrin in vitro by red blood cells of the duck. J. biol. Chem. 183, 757 (1950).
Shemin, D., C.S. Russell and T. Abramsky: The succinate-glycine cycle. J. biol. Chem. 215, 613 (1955).
Siemens, H. W.: Porphyria congenita mit Hypertrichosis. Hautarzt 8, 36 (1957).
Stich, W.: Kongenitale und hereditäre Porphyrien. Mod. Probl. Pädiat. 3, 139 (1957).
Sunderman Jr., F. W., and F. W. Sunderman: Practical considerations of diseases of porphyrin metabolism. Amer. J. clin. Path. 25, 1231 (1955).
Szodoray, L., u. L. Sümegi: Über die Nosologie der chronischen cutanen Porphyrie. Dermatologica (Basel) 90, 224 (1944).
Tappeiner, S., u. H. Tirschek: Das Syndrom der aktinisch-traumatischen bullösen Porphyrindermatose. Arch. Derm. Syph. (Berl.) 196, 65 (1953).
Taussig, L. R.: Hypersensitivity of the skin to light. Calif, west. Med. 39, 301 (1933).
Taylor, I. J., M. L. Solomon, G. S. Weiland and F. H. J. Figge: Chronic porphyria. J. Amer. med. Ass. 131, 26 (1946).
Thiele, R.: Ein Fall von genuiner Hämatoporphyrie mit Polyneuritis und Symptom Psychose. Mschr. Psychiat. Neurol. 55, 337 (1924).
Tio, T. H., and B. Leijnse: Porphyria cutanea tarda. A.M.A. Arch. Derm. 77, 568 (1958).
Tio, T. H., B. Leijnse, A. Jarrett and C. Rimington: Acquired porphyria from liver tumor. Clin. Sci. 16, 517 (1957).
Tulloch, L. G., and R. P. Warin: Porphyria cutanea tarda following jaundice. Brit. J. Derm. 69, 82 (1957).
Turner, W. J., and M. E. Obermayer: Studies on porphyria, II. A case of porphyria accompanied with epidermolysis bullosa, hypertrichosis and melanosis. Arch. Derm. Syph. (Chicago) 37, 549 (1938).
Vannotti, A.: Porphyrinurie und Porphyrinkrankheiten. In Handbuch der Inneren Medizin, herausgeg. von G. v. Bergman, W. Frey u. H. Schwiegk, Bd. VII/2, S. 779. Berlin-Göttingen-Heidelberg: Springer 1955.
Waldenstrom, J.: Studien Über Porphyrie. Acta med. scand. Suppl. 82 281 (1937). —
Waldenstrom, J.: Some observations on acute porphyria and other diseases with a change in the excretions of porphyrins. Acta med. scand. 83, 281 (1934).
Waldenstrom, J.: The porphyrias as inborn errors of metabolism. Amer. J. Med. 22, 758 (1957).
Waldenstrom, J., H. Fink u. W. Hoerburger: Über ein neues bei der akuten Porphyrie regelmäßig vorkommendes Uroporphyrin. Hoppe-Seylers Z. physiol. Chem. 233, 1 (1935).
Watson, C. J.: The manifestations of the different forms of porphyria in relation to chemical findings. Trans. Ass. Amer. Physicians 64, 345 (1951).
Watson, C. J.: Porphyria. Advances in Internal Medicine, edit. W. Dock and I. Snapper, Bd. VI, p. 234. Chicago: Year Book Publ. 1954.
Watson, C.J., V. Hawkinson, R.B. Capps and E. M. Rappaport: Studies of coproporphyria IV. The per diem excretion and isomer distribution in the urine in infectious hepatitis, infectious mononucleosis, and mechanical jaundice. J. clin. Invest. 28, 621 (1949).
Watson, C. J., V. Hawkinson, S. Schwartz and D. Sutherland: Studies of coproporphyrin. I. The per diem excretion and isomer distribution of co-proporphyrin in normal human urine. J. clin. Invest. 28, 447 (1949).
Watson, C. J., and E.A. Larson: The urinary coproporphyrins in health and disease. Physiol. Rev. 27, 478 (1947).
Watson, C. J., and S. Schwartz: A simple test for urinary porphobilinogen. Proc. Soc. exp. Biol. (N.Y.) 47, 393 (1941).
Watson, C. J., S. Schwartz and V. Hawkinson: Studies of the uroporphyrins: II. Further studies of the porphyrins of the urine, feces, bile and liver in cases of porphyria, with particular reference to a Waldenstrom type porphyrin behaving as an entity on the Tswett column. J. biol. Chem. 157, 345 (1945).
Wehrmacher, W. H.: New symptomatic treatment for acute intermittent porphyria. Arch. intern. Med. 89, 111 (1952).
Wells, G. C., and C. Rimington: Studies on a case of porphyria cutanea tarda. Brit. J. Derm. 65, 337 (1953).
Woods, S. M., H. A. Peters and S. A. M. Johnson: Cutaneous porphyria with porphobilinogenuria. A.M.A. Arch. Derm. 77, 559 (1958).
Wulf, K.: Beitrag zur Ätiologie der Lichtdermatosen. Arch. Derm. Syph. (Berl.) 197, 209 (1954).
Zeligman, I.: Urinary excretion of porphyrin in dermatoses. Arch. Derm. Syph. (Chicago) 54, 281 (1946).
Zeligman, I.: Red fluorescence of urine in Wood’s Light as aid in office diagnosis of porphyria. Arch. Derm. Syph. (Chicago) 61, 853 (1950).
Zeligman, I.: Porphyrins, porphyrinuria and porphyria. A.M.A. Arch. Derm. 74, 33 (1956).
Zeligman, I., and M. Baum: Porphyric bullous dermatosis. Arch. Derm. Syph. (Chicago) 58, 357 (1948).
Zuelzer, W. W., u. E. Kaplan: Persönliche Mitteilung, zit. von Watson 1954.
G. Ablagerung von Hämosiderin: Hämochromatose (S. 221)
Adams, W. S., A. Leslie and M. H. Levin: The dermal loss of iron. Proc. Soc. exp. Biol.(N.Y.) 74, 46 (1950).
Alper, T., D. V. Savage and T. H. Bothwell: Radioiron studies in a case of hemochromatosis. J. Lab. clin. Med. 37, 665 (1951).
Althausen, T. L., R. K. Doig, S. Weiden, R. Motteram, C. N. Turner and A. Moore: Hemochromatosis. A.M.A. Arch. intern. Med. 88, 553 (1951).
Aufderheide, A. C., H. L. Horns and R. J. Goldish: Secondary hemochromatosis. I. Transfusion (exogenous) hemochromatosis. Blood 8, 824 (1953).
Beyers, M. R., and S. E. Gitlow: Metabolism of iron in hemochromatosis. Amer. J. clin. Path. 21, 349 (1951).
Bomford, R. R., and C. P. Rhoads: Refractory anaemia. I. Clinical and pathological aspects. Quart. J. Med. 10, 175 (1941).
Bork, K.: Zur Lehre von der allgemeinen Hämochromatose. Virchows Arch. path. Anat. 269, 178 (1928).
Butt, H. R., u. R. M. Wilder: Hemochromatosis. Arch. Path. (Chicago) 26, 262 (1938).
Butt, H. R., u. R. M. Wilder: Case records of the Massachusetts General Hospital, Case 38 512. New Engl. J. Med. 247, 992 (1952).
Chodos,R. G., and J. F. Ross: Absorption of radioactive iron in normal, anemic and hemochromatotic subjects. Amer. J. Med. 14, 499 (1953).
Copp, D. H., and D.M. Greenberg: A tracer study of iron metabolism with radioactive iron. I. Methods, absorption and excretion of iron. J. biol. Chem. 164, 377 (1946).
Currin, J. F.: Occurrence of secondary hemochromatosis in patient with thalassemia major. Arch. intern. Med. 93, 781 (1954).
Davis Jr., W. D., and W. R. Arrowsmith: The effect of repeated bleeding in hemochromatosis. J. Lab. clin. Med. 36, 814 (1950).
Davis Jr., W. D., and W. R. Arrowsmith: The treatment of hemochromatosis by massive venesection. Ann. intern. Med. 39, 722 (1953).
Debré, R., G. Schapira, J. C. Dreyfus et F. Schapira: Métabolisme du fer chez les descendents de malades atteints de cirrhose bronzée. Bull. Soc. méd. Hop. Paris 68, 665 (1952).
Drabkin, D. L.: Metabolism of hemin chromoproteins. Physiol. Rev. 31, 345 (1951).
Dubach, R., S. T. E. Callender and C. V. Moore: Studies in iron transportation and metabolism. VI. Absorption of radioactive iron in patients with fever and with anemias of varied etiology. Blood 3, 526 (1948).
Eisenmenger, W. J.: Diskussion zu A. A. Fisher, Hemochromatosis. A.M.A. Arch. Derm. Syph. 66, 127 (1952).
Ellis, J. T., I. Schulman and C. H. Smith: Generalized siderosis with fibrosis of liver and pancreas, in Cooley’s (Mediterranean) anemia. Amer. J. Path. 30, 287 (1954).
Finch, C. A.: Iron metabolismus in hemochromatosis. J. clin. Invest. 28, 780 (1949).
Finch, C. A., M. Hegsted, T. D. Kinney, E. D. Thomas, C. E. Rath, D. Haskins, S. Finch and R. G. Fluharty: Iron metabolism. Pathophysiology of iron storage. Blood 5, 983 (1950).
Finch, S. C., and C. A. Finch: Idiopathic hemochromatosis, an iron storage disease. Medicine (Baltimore) 34, 381 (1955).
Goldish, R. J., and A. C. Aufderheide: Secondary hemochromatosis. II. Report of a case not attributable to blood transfusions. Blood 8, 837 (1953).
Granick, S.: Ferritin. J. biol. Chem. 164, 737 (1946).
Granick, S.: Iron metabolism and hemochromatosis. Bull. N.Y. Acad. Med. 25, 403 (1949).
Granick, S.: Iron metabolism. Bull. N.Y. Acad. Med. 30, 81 (1954).
Hahn, P. F., W. F. Bale, J.F. Ross, W.M. Balfour and G.H. Whipple: Radioactive iron absorption by gastro-intestinal tract. J. exp. Med. 78, 169 (1943).
Hall, T.: In der Diskussion zu Case Record of the Massachusetts General Hospital, Case 38512. New Engl. J. Med. 247, 992 (1952).
Haskins, D., A. R. Stevens Jr., S. Finch and C. A. Finch: Iron metabolism. Iron stores in man as measured by phlebotomy. J. clin. Invest. 31, 543 (1952).
Hedinger, C.: Zur Pathologie der Hämochromatose. Hämochromatose als Syndrom. Helv. med. Acta 20, suppl. 32 (1953).
Heilmeyer, L.: Die Hämochromatose: Klinik, Eisenstoffwechsel und Pathogenese. Acta haemat. (Basel) 11, 137 (1954).
Heilmeyer, L.: Neuere Ergebnisse der Eisenstoffwechselforschung bei der Hämochromatose. Dtsch. med. Wschr. 79, 280 (1954).
Hellier, F. F.: The nature and causation of the skin pigmentation in haemochromatosis. Brit. J. Derm. 47, 1 (1935).
Houston, J. C.: Phlebotomy for haemo-chromatosis. Effect of removing 52 pints of blood in sixteen months. Lancet 264, 766 (1953).
Houston, J. C., and R. H. S. Thompson: The diagnostic value of serum iron studies in haemochromatosis: Observations on seven patients. Quart. J. Med. 21, 215 (1952).
Howard, R. B., W. M. Balfour and R. Cullen: Extreme hyperferremia in two instances of hemochromatosis with notes on the treatment of one patient by means of repeated venesection. J. Lab. clin. Med. 43, 848 (1954).
Howell, J., and J. P. Wyatt: Development of pigmentary cirrhosis in Cooley’s anemia. Arch. Path. (Chicago) 55, 423 (1953).
Jeghers, H.: Pigmentation of the skin. New Engl. J. Med. 231, 181 (1944).
John, H. J.: Hemochromatosis without pigmentation of the skin. J. Amer. med. Ass. 112, 2272 (1939).
Kaufmann, E.: Hämochromatose. In Handbuch der Haut- und Geschlechtskrankheiten, herausgeg. von J. Jadassohn, Bd. IV/2, S. 1112. Berlin: Springer 1933.
Lawrence, R. D.: Haemochromatosis in three families and in a woman. Lancet 1949I, 736.
Löhr, K., u. H. Reinwein: Konkordantes Auftreten von Lebercirrhose und Diabetes mellitus (Hämochromatose) bei eineiigen Zwillingen. Dtsch. Arch. klin. Med. 200, 53 (1952).
Magnuson, H. J., and B. O. Raulston: The iron content of the skin in hemochromatosis. Ann. intern. Med. 16, 687 (1942).
McCance, R. A., and E. M. Widdowson: The absorption and excretion of iron following oral and intravenous administration. J. Physiol. (Lond.)94, 148 (1938).
Montgomery, H., and P. A. O’Leary: Pigmentation of the skin in Addison’s disease, acanthosis nigricans and hemochromatosis. Arch. Derm. Syph. (Chicago) 21, 970 (1950).
Muirhead, E. E., G. Crass, F. Jones and J. M. Hill: Iron overload (hemosiderosis) aggravated by blood transfusions. Arch. intern. Med. 83, 477 (1949).
Norris, R. P., and F. J. McEwen: Exogenous hemochromatosis following multiple blood transfusions. J. Amer. med. Ass. 143, 740 (1950).
Peterson, R. E., and R. H. Ettinger: Radioactive iron absorption in siderosis (hemochromatosis) of the liver. Amer. J. Med. 15, 518 (1953).
Pirart, J., et J. Franken: Traitement de Fhémochromatose par la testosterone; étude biologique de 9 cas. Sem. Hôp. Paris 29, 2448 (1953).
Rath, C. E., and C. A. Finch: Chemical, clinical and immunological studies on the products of human plasma fractionation. XXXVIII. Serum iron transport. Measurement of iron-binding capacity of serum in man. J. clin. Invest. 28, 79 (1949).
Robert, P., u. H. Zürcher: Pigmentstudien, 1l. Mitteilung. Über den Einfluß von Schwermetallverbindungen, Hämin, Vitaminen, Aminosäuren, mikrobiellen Toxinen, Hormonen und weiteren Stoffen auf die Dopamelaninbildung in vitro und die Pigmentbildung in vivo. Dermatologica (Basel) 100, 217 (1950).
Rogers, W. F.: Familial hemochromatosis: with comments on adrenal function in hemochromatosis. Amer. J. med. Sci. 220, 530 (1950).
Schwartz, S.O., and S. A. Blumenthal: Exogenous hemochromatosis resulting from blood transfusions. Blood 3, 617 (1948).
Sheldon, J. H.: Haemochromatosis. London: Oxford University Press 1935.
Shelley, W. B., and H. J. Hurley: The physiology of the human axillary apocrine sweat gland. J. invest. Derm. 20, 285 (1953).
Soltermann, W.: Die Bedeutung des Eisennachweises in der Haut für die Diagnose einer Hämochromatose unter besonderer Berücksichtigung der Axillargegend und der apokrinen Schweißdrüsen. Dermatologica (Basel) 112, 335 (1956).
Stauffer, M. H., H. R. Butt and M. B. Dockerty: Hemochromatosis: clinical features and methods of diagnosis in 27 cases. Gastroenterology 27, 31 (1954).
Surgenor, D.M., B. A. Koechlin and L. E. Strong: Chemical, clinical and immunological studies on the products of human plasma fractionation. XXXVII. The metal-combining globulin of human plasma. J. clin. Invest. 28, 73 (1949).
Wallerstein, R. O., and S. L. Robbins: Hemochromatosis after prolonged oral iron therapy in a patient with chronic hemolytic anemia. Amer. J. Med. 14, 256 (1953).
Warren, S., and W. L. Drake: Primary carcinoma of the liver in hemochromatosis. Amer. J. Path. 27, 573 (1951).
Warthin, T. A., E. W. Peterson and J. H. Barr Jr.: The treatment of idiopathic hemochromatosis by repeated phlebotomy. Ann. intern. Med. 38, 1066 (1953).
Wenderoth, H.: Kritische Betrachtungen Über das Hämosideroseproblem. Dtsch. med. Wschr. 79, 572 (1954).
Wyatt, J. P., H. R. Mighton and V. Moragues: Transfusional siderosis. Amer. J. Path. 26, 883 (1950).
Zeltmacher,K., and M. Bevans: Aplastic anemia and its association with hemochromatosis. Arch. intern. Med. 75, 395 (1945).
H. Carotinosis (Carotinämie, Aurantiasis cutis, Xanthosis) (S. 232)
Almond, S., and R. F. L. Logan: Carotinaemia. Brit. med. J. 1942II, 239.
Arn-rich, L.: The effect of hypothyroidism on the metabolism of carotene in dogs. J. Nutr. 56, 35 (1955).
Auckland, G.: A case of carotinaemia. Brit. med. J. 1952II, 267.
Boeck, W. C., and W. M. Yater: Xanthemia and xanthosis (carotinemia): a clinical study. J. Lab. clin. Med. 14, 1129 (1929).
Bomford, R.: Anaemia in myxoedema: and the role of the thyroid gland in erythropoesis. Quart. J. Med. 7, 495 (1938).
Brandaleone, H., and E. P. Ralli: Fasting blood carotene level in normal and diabetic individuals. Proc. Soc. exp. Biol. (N.Y.) 32, 200 (1934).
Clausen, S.W., and A. B. McCoord: The Carotinoids and vitamin A of the blood. J. Pediat. 13, 635 (1938).
Clausen, S.W., and A. B. McCoord: Cohen of Birkenhead, The Lord: Observations on caroten-emia. Ann. intern. Med. 48, 219 (1958).
Edsall, J. T.: The plasma proteins and their fractionation. Advanc. Protein Chem. 3, 383 (1947).
Edwards, E. A., and S. Q. Duntley: The pigments and color of living human skin. Amer. J. Anat. 65, 1 (1939).
Escamilla, R. F.: Carotinemia in myxedema. Explanation of the typical slightly icteric tint. J. clin. Endocr. 2, 33 (1942).
Escamilla, R. F., H. Lisser and H. C. Shepardson: Internal myxedema; report of a case showing ascites, cardiac, intestinal and bladder atony, menorrhagia, secondary anemia and associated carotinemia. Ann. intern. Med. 9, 297 (1935).
Fasold,H., u. E. R. Heidemann: Über die Gelbfärbung der Milch thyreopriver Ziegen. Z. ges. exp. Med. 92, 53 (1934).
Greene, C. H., and L. M. Blackford: Carotinemia. Med. Clin. N. Amer. 10, 733 (1926).
Jeghers, H.: Skin changes of nutritional origin. New Engl. J. Med. 228, 678 (1943).
Josephs, H. W.: Studies in vitamin A. Relation of vitamin A and carotene to serum lipids. Bull. Johns Hopk. Hosp. 65, 112 (1939). —
Josephs, H. W.: Studies on vitamin A. Vitamin A and total lipid of the serum in pneumonia. Amer. J. Dis. Child. 65, 712 (1943). —
Josephs, H. W.: Hypervitaminosis A and carotenemia. Amer. J. Dis. Child 67, 33 (1944). —
Josephs, H. W.: The carotenemia of hypothyroidism. J. Pediat. 41, 784 (1952).
Kaufmann, E.: Aurantiasis cutis (Baelz). In: Handbuch der Haut- und Geschlechtskrankheiten, herausgeg. von J. Jadassohn, Bd. IV/2, S. 1090. Berlin: Springer 1933.
Mandelbaxjm, T., S. Candel and S. Millman: Hypothyroidism, hyperlipemia and carotinemia. J. clin. Endocr. 2, 465 (1942).
Maechionini, A., u. C. Patel: Klinische und experimentelle Untersuchungen Über den Vitamin A- und Carotingehalt des menschlichen Blutserums bei Hautkrankheiten. Arch. Derm. Syph. (Berl.) 175, 419 (1937).
Moore, T.: Vitamin A reserves of human liver in health and disease with special reference to scope of vitamin A as an anti-infective agent. Lancet 1932, 669.
Morton, R. A., and T. W. Goodwin: Carotenoids and vitamin A. Brit. med. Bull. 12, 37 (1956).
Palmer, L. S.: The chemistry of vitamin A and substances having a vitamin A effect. J. Amer. med. Ass. 110, 1748 (1938).
Pariente, A. C., C. H. Present and E. P. Ralli: A case of carotinemia and diabetes mellitus with necropsy report and analyses of liver for carotene, vitamin A, total fat and cholesterol. Amer. J. Med. Sci. 192, 365 (1936).
Rabinowitch, I. M.: Carotinaemia and diabetes. Canad. med. Ass. J. 18, 527 (1928).
Rabinowitch, I. M.: Carotinemia and diabetes. II. The relationship between the sugar, cholesterol and carotin contents of blood plasma. Arch. intern. Med. 45, 586 (1930).
Ralli, E. P., H. Brandaleone and T. Mandelbaum: Studies on the effect of the administration of carotene and vitamin A in patients with diabetes mellitus. J. Lab. clin. Med. 20, 1266 (1935).
Ralli, E. P., A. C. Pariente, H. Brandaleone and S. Davidson: Effect of carotene and vitamin A on patients with diabetes mellitus. J. Amer. med. Ass. 106, 1975 (1936).
Reich, P., H. Shwachman and J. M. Craig: Lycopenia, a variant of carotenemia. New Engl. J. Med. 262, 263 (1960).
Rosenberg, A., and A. E. Sobel: In vitro conversion of carotene to vitamin A in the isolated small intestine of the rat. Arch. Biochem. 44, 320 (1953).
Stannus, H.S.: Hyperlipochromia (carotinaemia: xanthosis cutis). Internat. Clin.,39. ser. 1, 146 (1929).
Stepp, W., u. H. Wendt: Einige Beobachtungen Über das Verhältnis von Carotin zu Vitamin A im menschlichen Blutserum. Dtsch. Arch. klin. Med. 180, 640 (1937).
Stueck, G. A., G. Flaum and E. P. Ralli: The serum carotene in diabetic patients. J. Amer. med. Ass. 109, 343 (1937).
Thomson, J. G.: Über Lipochrome im menschlichen Körper. Z. ges. exp. Med. 92, 692 (1934).
Wendt, H.: Über Veränderungen im Karotin-Vitamin-A-Haushalt beim Myxödem und bei Kretins. Münch. med. Wschr. 82, 1679 (1935).
White, F.D., and E. M. Gordon: Estimation of serum carotene. J. Lab. clin. Med. 17, 53 (1931).
Wolff, L. K.: On quantity of vitamin A present in human liver. Lancet 123, 617 (1932).
Author information
Authors and Affiliations
Editor information
Rights and permissions
Copyright information
© 1963 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Lever, W.F. (1963). Ablagerungskrankheiten körpereigener Stoffwechselprodukte. In: Cottini, G.B., et al. Nicht Entzündliche Dermatosen I. Handbuch der Haut- und Geschlechtskrankheiten, vol 3 / 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-87623-3_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-87623-3_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-87624-0
Online ISBN: 978-3-642-87623-3
eBook Packages: Springer Book Archive